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1. Introduction 
For every multicellular organism, programmed cell death (PCD) is a constant part of daily 
processes, at every developmental step and all ages. It is an essential mechanism to 
maintain cellular homeostasis by balancing biosynthetic and catabolic processes. It rids the 
organism of unwanted or damaged cells without causing an immune response. There are 
three major forms of PCD, type I cell death, also called apoptosis (Kerr et al. 1972) and type 
II cell death, referred to as autophagic cell death (Levine and Klionsky 2004). Type III cell 
death also known as necrosis, differs from autophagy and apoptosis. In contrast to type I and 
II PCD, this form of cell death is not immunological neutral: after swelling of the cell, the 
contents of cells subjected to necrosis are spilled into the surrounding tissue, often resulting 
in inflammation (Golstein and Kroemer 2007). Although necrosis was believed to be an 
unguided form of cell death, recent investigations in the field demonstrated a connection 
between the receptor-interacting serine/threonine-protein kinase (RIP) and necrosis, 
suggesting that necrosis is a partially regulated process (Holler et al. 2000; Vercammen et al. 
1998). This led to the idea of necroptosis, a form of programmed necrotic cell death. 
Apoptotic cell death is characterised, but not exclusively defined by chromatin condensation, 
nuclear fragmentation, the presence of proteolytically active caspases and plasma 
membrane blebbing (Kroemer et al. 2009). Primarily, autophagy is a cell survival process 
during starvation. However, ongoing autophagy and thus resulting cell digestion was 
reported to be a cell death mechanism as well (Denton et al. 2011; Levine and Yuan 2005; 
Galluzzi et al. 2008). Nevertheless, the characteristics of autophagic cell death are beyond 
dispute: The sequestration of cytoplasmic content in a de novo formed double- or 
multi-membrane-bound structure, the so-called autophagosome (Stromhaug and Klionsky 
2001), a process that can get out of control and result in digestion of the whole cell. All three 
forms of PCD have one thing in common: they are evolutionary conserved mechanisms that 
shape physiologically relevant processes, such as cell development, homeostasis and 
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differentiation. Moreover, apoptosis and autophagy are highly relevant in a multitude of 
different diseases, be it cancer, infection or inflammatory diseases (Mizushima et al. 2008; 
Ewald et al. 2011; Prescott et al. 2007). Apoptosis and autophagy intersect at multiple points, 
partly share certain upstream signalling molecules (Matsuzawa et al. 2012; Ivanov and Ronai 
2000) and can act in a synchronised manner or mutually exclude each other (Maiuri et al. 
2007). 
 
1.1 Autophagy 
1.1.1 General considerations about autophagy 
The term autophagy is a combination of the greek words “auto” -self and “phagein” –to eat, 
thus meaning “to digest oneself”. True to its name, autophagy is a catabolic process, which 
involves the sequestration of cytoplasmic contents into membrane vesicles and their 
subsequent degradation. Originally, autophagy was found in 1962 by Ashford and Porter 
(Ashford and Porter 1962). They called their discovery “microbody”, which they observed in 
rat livers. They described it as portions of the cytoplasm set aside for hydrolysis with the 
general purpose of providing the protoplast with breakdown products for use in physiological 
reorientation. The term autophagy was coined one year later in 1963 (De Duve 1963). 
However, the molecular mechanisms of this engulfment process were largely discovered 
years later in yeast by the group of Ohsumi (Matsuura et al. 1997; Wada et al. 1992). The 
use of genetic analysis was mostly responsible for these findings. Progress in experiments 
with Saccharomyces Cerevisiae, Hansenula polymorpha and Pichia pastoris led to the 
identification of a whole gene family, which is conserved in all species from yeast to men 
(Reggiori and Klionsky 2002; Wang and Klionsky 2003). This fact emphasises the 
importance of this mechanism. The function of these so called AuTophaGy-related, or ATG, 
genes were then dissected in numerous studies (Mizushima et al. 1998; Shintani et al. 1999; 
Tanida et al. 2001; Stromhaug and Klionsky 2001; Nemoto et al. 2003; Levine and Klionsky 
2004). 
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The best-known function of autophagy is the digestion of unneeded/unwanted cellular 
content in order to maintain cell homeostasis and subsequent recycling of cellular content. 
Autophagy is one of two cellular mechanisms that performs this function, the other being 
ubiquitinylation and subsequent proteasomal degradation (Hershko et al. 1981). Autophagy 
is also needed for the defence of the cell against intracellular pathogens (Tattoli et al. 2012; 
Knodler and Celli 2011). In addition, the deregulation of the autophagic machinery plays a 
major role in many diseases, especially neurodegenerative ones (Rubinsztein et al. 2005). 
 
1.1.2 The three different forms of autophagy and their role 
There are three main forms of autophagy: microautophagy, chaperone-mediated autophagy 
(CMA) and macroautophagy. Microautophagy is a non-selective lysosomal degradation 
process, which involves the direct engulfment of cytoplasmic cargo by autophagic tubes at 
the boundary membrane of a lysosome (Sahu et al. 2011; Li et al. 2012). These autophagic 
tubes mediate both the invagination and vesicle scission into the lumen. The contents of 
these vesicles are subsequently degraded by lysosomal acidification. Additionally, 
microautophagy is described as a selective process, but whether this is true in yeast only ( Li 
et al. 2012) or also in mammals (Sahu et al. 2011) remains unclear. In contrast to this, CMA 
is reported to be an exclusive degradation process of individual soluble proteins by 
lysosomes. A unique feature of CMA is that proteins reach the lysosomal lumen by directly 
crossing the lysosomal membrane (Koga and Cuervo 2011). This is accomplished by the 
chaperone protein Hsc70 (heat shock cognate 70) and cochaperones. They recognize 
cytosolic proteins, which contain a KFERQ-like pentapeptide and bind to the lysososomal 
protein LAMP-2a, which acts as a receptor and delivers the unfolded proteins into the 
lysosomal lumen (Orenstein and Cuervo 2010; Mizushima and Komatsu 2011). However, 
best investigated is the process of macroautophagy, which is the focus of this work and is 
hereafter referred to simply as autophagy. 
During autophagy, a damaged or otherwise obsolete organelle or portions of the cytoplasm 
are sequestered in the so-called phagophore, which becomes enlarged by elongation of the 
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membrane (Chen and Klionsky 2011; Tooze and Yoshimori 2010). When the phagophore is 
sealed and forms an enclosed structure, it is called an autophagosome (Fig. 1). During later 
steps of autophagosomal maturation, it fuses with a lysosome to become the autolysosome. 
In this way, the content becomes acidified and is thus able to break the constituents down 
into amino acids (Levine and Deretic 2007).  
 
Figure 1: Schematics of the three main stages of the autophagic machinery: Initiation, 
elongation and maturation.  
During initiation, the phagophore engulfs cytosolic contents and organelles by an isolation membrane. 
The phagophore is elongated and closes eventually, subsequently followed by fusion with a lysosome. 
Modified according to (Levine and Deretic 2007). 
 
Of note, the origin of this particular, double-layered membrane remains unknown. However, 
the mitochondrial membrane, the endoplasmatic reticulum (ER), the Golgi and the plasma 
membrane were reported to play a role in the formation of the autophagosomal membrane 
(Hailey et al. 2010; Tooze and Yoshimori 2010; Ravikumar et al. 2010). Although the exact 
mechanisms are not yet fully understood, it is commonly agreed that some unknown 
machinery must dock at, or be delivered to an assembly point or platform that has been 
named PAS (pre-autophagosomal structure or phagophore assembly site) (Tooze and 
Yoshimori 2010).  
The maintenance of cell homeostasis during times of starvation or aging is probably one of 
the best-examined autophagy-inducers (Cuervo et al. 2005). Starvation initiates autophagy, 
so that supernumerous cellular contents are recycled and the amino acids can be utilised for 
important cellular processes necessary for cell survival (Jia and Levine 2007). Additionally, 
autophagy is able to rid the cells of unwanted and potentially harmful cellular content, here 
the clearance of mitochondria is probably the best known example (Mizushima and Klionsky 
Initiation Elongation Maturation
AutolysosomeAutophagosomeCytosol
Isolation 
membrane
Mitochondrium
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2007). Along these lines, mitochondria are removed by autophagy during the terminal 
differentiation step of erythrocytes and T cells (Novak 2012).  
Autophagy is also used for the defence against intracellular pathogens, a process called 
xenophagy. How pathogens are specifically targeted for degradation and their individual 
escape mechanisms are highly diverse between different pathogens. For a variety of 
intracellular pathogens e.g. Listeria monocytogenes, Mesorhizobium huakuii and Rickettsia 
conorii, these mechanisms could already be studied, (Kirkegaard et al. 2004). In vitro studies 
also proved autophagy to be relevant in the clearance of viruses, such as herpes simplex 
virus type I (HSV-1) and the Sindbis virus (Liang et al. 1998; Orvedahl et al. 2007). 
Interestingly, remnants of autophagic breakdown seem to be later cross presented via MHC 
Class II molecules (Fig. 2), implying an important role of autophagy in an immunological 
context as well (Menéndez-Benito and Neefjes 2007; Schmid et al. 2007; Schmid and Münz 
2007).
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Figure 2: Schematic representation of three important aspects of macroautophagy in innate 
and adaptive immunity.  
Left: In xenophagy, autophagy is directly involved in degradation of an intracellular pathogen. Middle: 
Autophagy may be involved in delivering viral nucleic acid to TLR7 in order to help the cell mount a 
type1 IFN immune response. Right: Autophagy might also be involved in adaptive immunity by 
mounting endogenously synthesised antigens onto major histocompatibility complex (MHC) class II 
molecules for antigen presentation to CD4+ T cells. Modified according to (Levine and Kroemer 2008). 
 
Apart from other implications, autophagy, or more specific its dysregulation, is also heavily 
involved in a number of diseases. Most strikingly are the neurodegenerative diseases, such 
as Alzheimer’s, transmissible spongiform encephalopathy, Parkinson’s and Huntington’s 
(Steffan 2010; Rubinsztein et al. 2007). However, recent reports indicate that autophagy also 
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seems to be involved in cancer, for example by serving as a barrier to limit tumor initiation 
(Kimmelman 2011; Wojtkowiak and Gillies 2012; Hu et al. 2012). 
1.1.3 Regulation and molecular events in autophagy 
As described in 1.1.2, autophagy can be separated into three major steps: initiation, 
elongation and maturation. To simplify the description of the events regulating autophagy 
and to describe them in detail, the mammalian nomenclature is used. Additionally, only the 
most prominent isoform of each Atg protein will be used, although multiple ones exist in 
mammals, but not in yeast. The difference in function between diverse isoforms is a topic of 
ongoing research.  
In the initial step, the main sensor of the overall state of the cell in respect to starvation or 
growth factor abundance is the mammalian target of rapamycin (mTOR). mTOR is a 
conserved Ser/Thr protein kinase that regulates cell growth, cell cycle progression, nutrient 
import, protein synthesis and autophagy (Sarbassov et al. 2005). mTOR is about 280 kDa in 
size and is a member of the phosphatidylinositol-related kinases (PIKK) group (Bhaskar and 
Hay 2007). It is evolutionary conserved and all eukaryotic genomes contain a single TOR 
gene (Pattingre et al. 2008). Functionally, mTOR acts in two different complexes: the 
mTORC1 and the mTORC2 complex.  
 
Figure 3: Depiction of the two distinct TOR complexes, mTORC1 and mTORC2.  
mTORC1 is in complex with raptor and mLST8 and is rapamycin-sensitive. mTOR2 is rapamycin 
insensitive and forms a complex with rictor, mLST8 and SIN1. Modified according to (Bhaskar and 
Hay 2007).  
Raptor
Heat Repeats FAT FRB Kinase NR FA
TC
mLST8
Rictor
Heat Repeats FAT FRB Kinase NR FA
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mLST8
mTOR
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mTORC1 is comprised of mLST8 and Raptor and is sensitive to rapamycin (Menéndez-
Benito and Neefjes 2007; Hara et al. 2002; Schmid et al. 2007; Schmid and Münz 2007). 
mTORC2 is composed of mTOR, mLST8, rictor, SIN1 and protor and is, in contrast to 
mTORC1, insensitive to rapamycin treatment (Levine and Kroemer 2008; Cybulski and Hall 
2009). Although mTORC2 is insensitive to rapamycin, long-term rapamycin treatment can 
inhibit the assembly of new mTORC2, thus indirectly inhibiting mTORC2 (Steffan 2010; 
Sarbassov 2005; Rubinsztein et al. 2007). The role of mTORC2 is much less defined than 
that of the mTORC1 complex. Publications show its involvement in the activation of Akt/PKB 
regulation by phosphorylation of a serine (Kimmelman 2011; Sarbassov 2005; Wojtkowiak 
and Gillies 2012; Hu et al. 2012). Interestingly, upstream events of mTORC1 did not seem to 
be altered when mTORC2 kinase activity was abolished by a knockdown of the rictor 
complex (Sarbassovet al. 2005; Hresko and Mueckler 2005). Therefore, mTORC2 does not 
seem to be located upstream of mTORC1. In summary, it can be concluded that the interplay 
between mTORC1 and mTORC2 is not yet fully understood and further experimental work 
has to be done (Bhaskar and Hay 2007; Lee et al. 2007). 
The first step leading to the initiation of autophagy after mTOR senses starvation signals of 
the cell is the binding of the ULK1 complex. This complex consists of 4 proteins, the ULK1 
serine/threonine protein kinase (mammalian ortholog of yeast Atg1), Atg13, FIP200 
(mammalian homolog of Atg17) and the Atg13 binding protein Atg101 (Pattingre et al. 2008; 
Ganley et al. 2009; Hosokawa et al. 2009; Hosokawa et al. 2009). mTORC1 is inccoperated 
into this complex, phosphorylating ULK1 and Atg13 (Mehrpour et al. 2010). Under conditions 
of nutrient starvation or upon rapamycin treatment, mTORC1 disassociates from this 
complex and thereby enables ULK1 to autophosphorylate and also to phosphorylate Atg13 
and FIP200 (Mehrpour et al. 2010). 
Another complex responsible for the initiation of phagophore membrane is the Beclin 1:class 
III phosphatidylinositol 3-kinase (PI3K) complex. It consists of the class III PI3K hVps34, its 
regulatory protein kinase p150, Beclin 1 and the mammalian homolog of Atg14 (Bhaskar and 
Hay 2007; Itakura et al. 2008; Sun et al. 2008; Mehrpour et al. 2010). Beclin 1 is a major 
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interaction partner of multiple proteins, be it cellular ones such as MyD88, AMBRA1 and 
UVRAG, (Hara et al. 2002; Liang et al. 2006; Fimia et al. 2007; Pattingre et al. 2008) or 
antiapoptotic ones like the Bcl-2 family members, e.g. Bcl-XL (Cybulski and Hall 2009; Levine 
et al. 2008). The interaction with Bcl-2 family members blocks the induction of autophagy by 
inhibiting the formation of phosphatidylinositol 3-phosphate (PtdIns3P), also known as 
omegasome (Sarbassov 2005; Liang et al. 1998; Furuya et al. 2005). In conclusion, Bcl-2 is 
not only an apoptotic, but also an autophagic inhibitor protein. 
 
Figure 4: Regulation of autophagy and its relationship with apoptotic mediators. 
Depicted are the main complexes responsible for the initiation, the expansion and the maturation of 
the autophagosomal membrane. Depicted in red are the mediators of apoptosis involved in 
autophagy. Purple are protein kinases with substrates in the autophagic machinery. Green is LC3. 
Modified according to (Mehrpour et al. 2010). 
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Subsequently, the Beclin 1/hVps34 complex interacts with WIPI-1 via its PtdIns3P-binding 
site (Hresko and Mueckler 2005; Proikas-Cezanne et al. 2004). WIPI-1 and Atg2 are both 
linked to the biogenesis of the autophagosome, but the exact mechanism remains 
unresolved (Lee et al. 2007; Mehrpour et al. 2010). Also not known is how the 
Beclin 1/hVps34 complex acts in unison with the ULK1 complex (Fig. 4). In summary, both 
complexes together initiate the formation of the autophagosomal membrane and provide the 
interface between sensing the general state of the cell and the activation of the autophagic 
machinery. 
After initiation, the elongation phase is coined by two different ubiquitin-like conjugation 
systems, the LC3 (Atg8 in yeast) and the Atg12 system (Ganley et al. 2009; Ohsumi 2001; 
Hosokawa, Sasaki, et al. 2009; Yorimitsu and Klionsky 2005; Hosokawa et al. 2009). Atg12 
is a 186-amino-acid hydrophilic protein, which is homologous to ubiquitin (Itakura et al. 2008; 
Mizushima et al. 1998; Sun et al. 2008; Mehrpour et al. 2010). Here, it was reported that 
Atg12 covalently binds to Lys149 of the Atg5 (Liang et al. 2006; Mizushima et al. 1998; Fimia 
et al. 2007; Pattingre et al. 2008). This complex formation is dependent on Atg7 and Atg10 
(Levine et al. 2008; Mizushima et al. 1998). Atg16 stabilises the Atg12-Atg5 complex and 
anchors it to the membrane (Liang et al. 1998; Matsushita et al. 2007; Furuya et al. 2005). 
It should be noted, that Atg5 is a key protein in autophagosome formation and in the 
autophagic process in general. Although there are reports of an Atg5-independent 
autophagosomal pathway (Mehrpour et al. 2010; Nishida et al. 2009), the majority of 
autophagy seems to be Atg5-dependent. A fact which is emphasised by a study from Kuma 
and colleagues: Atg5-/- mice do not survive the early neonatal starvation period (Kuma et al. 
2004). The fatality of this defect clearly shows the unique role Atg5 plays in the 
autophagosomal pathway. Of note, Atg5 expression also seems to be directly connected to 
certain autoimmune diseases, for example multiple sclerosis and autoimmune demyelination 
(Mehrpour et al. 2010; Alirezaei et al. 2009). 
Subsequently, the Atg12-Atg5 conjugation system initiates the second conjugation system. 
This one is important for the elongation process, namely the LC3 (Atg8) conjugation system 
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(Fig.5). In this system the COOH terminus of LC3 is conjugated to the polar head of 
phosphatidylethanolamine (PE) (Ohsumi 2001; Scarlatti et al. 2009; Yorimitsu and Klionsky 
2005). LC3-PE formation (also known as LC3-II) depends on Atg7 and Atg3, which have a 
function similar to the E1 and E2 enzymes in the ubiquitin pathway, respectively (Mizushima 
et al. 1998; Ichimura et al. 2000; Tanida et al. 1999; Meijer and Codogno 2004). Atg4 primes 
LC3 for conjugation by exposing a glycine residue at the COOH terminus (the form of LC3 
with this glycine exposed is also known as LC3-I) (Scarlatti et al. 2009). Interestingly, LC3 is 
recruited to both the internal and the external surface of the expanding autophagosomal 
membrane, a fact which predestines the protein as a marker for autophagosomes (Noda et 
al. 2009; Mehrpour et al. 2010). After the closure of the autophagosomal membrane, LC3-PE 
is released in an Atg4-dependent way, along with all other Atg proteins assembled on the 
phagophore (Kirisako et al. 2000). In contrast to this, the LC3 on the inner surface of the 
autophagosomal membrane remains and is later subjected to acidification and lysis along 
with the rest of the autophagosomal cargo (Ichimura et al. 2000; Kabeya et al. 2000). 
 
Figure 5: Schematic overview of the molecular events in autophagosomal maturation.  
Special emphasize lies on the elongation system and its two ubiquitin-like conjugation systems: Atg12 
and LC3. Modified according to (Levine and Deretic 2007).  
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Additionally, LC3 performs another important role in selective autophagy: LC3-II is able to 
bind to p62/SQSTM1 and thus targets ubiquitinylated proteins for autophagosomal 
degradation (Bjørkøy et al. 2005; Bjørkøy et al. 2006). In detail, p62 can bind ubiquitinylated 
proteins through its ubiquitin-associated (UBA) domain and LC3-II through its LC3-interacting 
region (LIR) (Bjørkøy et al. 2005; Bjørkøy et al. 2006). p62 thereby seems to be the missing 
link between ubiquitinylation and autophagy. Interestingly, although both forms of LC3 can 
bind p62, only the lipidated form of LC3, bound to the autophagosomal membrane, is 
involved in p62 recruitment to autophagosomes (Fig. 6) (Shvets et al. 2011). 
 
Figure 6: A model for the selective autophagic degradation of protein aggregates. 
p62 binds to ubiquitylated proteins and LC3-PE (LC3 II) and thus specifically targets proteins for 
autophagosomal degradation. Modified according to (Tyedmers et al. 2010).  
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The last step in the autophagosomal process is maturation, which is largely defined by the 
fusion of the autophagosome with a lysosome (Wang et al. 2002; Wang et al. 2003). This 
results in the formation of an autophagolysosome and subsequent degradation of 
internalised proteins (Teter et al. 2001; Nakamura et al. 1997). However, a closer look at this 
subject shows that a direct fusion of autophagosomes with lysosomes seems to be the 
exception, not the norm. Before the autophagosome fuses with a lysosome, it usually merges 
with an endosome or a multivesicular body (Razi et al. 2009; Stromhaug and Seglen 1993; 
Fass et al. 2006). 
The maturation of autophagosomes, here explicitly the fusion of autophagosomes with 
lysosomes, is controlled by proteins which are involved in controlling the membrane fusion 
during intracellular transport (Rab GTPase, SNARE and ESCRT proteins, and the function of 
acidic degradative compartments (v-ATPase, LAMP proteins, lysosomal carriers, and 
lysosomal hydrolases)) (Mehrpour et al. 2010; Eskelinen 2005; Fader and Colombo 2009; 
Rusten and Stenmark 2009). 
Most interestingly, Beclin 1, previously mentioned to play a role in the initiation of autophagy, 
is also involved in the maturation of autophagosomes. During autophagosome maturation, it 
can interact with Rubicon or UVRAG (Liang et al. 2006; Matsunaga et al. 2009; Zhong et al. 
2009). When forming a complex with hVps34, UVRAG and Rubicon, Beclin 1 represses the 
maturation of autophagosomes. In contrast the same Beclin 1/hVps34/UVRAG complex, but 
without Rubicon, enhances autophagosomal maturation (Matsunaga et al. 2009; Zhong et al. 
2009). These results demonstrate that Beclin 1 acts at two distinct steps of the 
autophagosomal pathway and is thereby an important regulator of autophagy. 
 
1.1.4 Autophagy in T cells 
One of the first studies that could prove the essential role of autophagy in T cells was 
investigating the role of Atg5 and in T cell survival and proliferation (Pua et al. 2007). The 
authors were the first to show autophagosome formation in primary mouse T lymphocytes. 
Interestingly, Pua and colleagues identified fully mature lymphocytes in Atg5-/- bone marrow 
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chimeric mice. However, the Atg5-/-CD8+ lymphocytes were largely decreased in numbers 
and Atg5-/-CD4+ lymphocytes were unable to proliferate efficiently upon T cell receptor (TCR) 
stimulation (Pua et al. 2007). More studies followed that could demonstrate a role of 
autophagy in T cells. More recently, T cells with a conditional Atg7-deficiency were found to 
exhibit a proliferation defect similar to caspase 8-/- T cells upon lymphocytic choriomeningitis 
virus (LCMV) infection (Ch'en et al. 2011). The group further showed that in resting T cells 
the autophagosomal content was mainly composed of mitochondria, whereas in activated 
T cells it was largely made of cytosolic contents (Ch'en et al. 2011). This would argue for an 
energy-providing function in activated T cells as opposed to a cell proteome- and 
organelle-renewal function in resting T cells. Also using Atg7-/- T cells, a recent study by the 
same group that demonstrated the importance of Atg5 in T cell proliferation, revealed that 
upon a severe defect of autophagy, influx of Ca2+ is impaired (Jia et al. 2011). They 
demonstrated that this defective Ca2+ influx is due to the inability of autophagy-defective T 
cells to deplete the intracellular Ca2+ stores (Jia et al. 2011). Moreover, mice with 
lymphocytes deficient in Vps34 also showed a severely reduced T lymphocyte compartment 
(Mcleod et al. 2011). The reason for this reduction was found to be a large decrease in 
expression of IL-7Rα on the cell surface, an essential surface receptor for naïve T 
lymphocytes (Mcleod et al. 2011). These experiments clearly show the important role of 
autophagy in maintaining cellular homeostasis in T cells, be it in providing energy or in 
signalling events.  
However, autophagy in T cells has been found to have pro-apoptotic functions as well, a fact 
that will be discussed later in this work (chapter 1.3.4). Additionally, recent publications could 
link autophagy to autoimmune diseases, including systemic lupus erythematosus (SLE). 
T cells have been shown to play a cardinal role in SLE initiation, progression and execution 
(La Cava 2009). Recent publications could link mTOR activation to abnormal activation of 
lymphocytes in SLE (Fernandez and Perl 2009; Fernandez and Perl 2010). Here, mTOR is 
involved in SLE through its mitochondrial hyperpolarisation (MHP) function, which is 
triggered by glutathione depletion and increased nitric oxide levels, both of which are 
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commonly observed in SLE patients (Nagy et al. 2004). Additionally, single-nucleotide 
polymorphisms (SNPs) in Atg5 could be linked to increased SLE susceptibility in a 
genome-wide study of 1745 individuals (Zhou et al. 2011). Taken together, these studies 
demonstrate the importance of autophagy in T cell survival, homeostasis and immunity. 
 
 
1.2 Apoptosis 
1.2.1 General considerations about apoptosis 
Apoptosis is one of the most-investigated cell biological topics, which also exerts a high 
impact on immunology worldwide and still is a subject of intense research. The term 
apoptosis is Greek and can be translated as apo- off ptosis- falling, thus, the falling of a dead 
leaf. As already mentioned, apoptosis is characterised by several different cellular events, 
such as e.g. membrane blebbing (Kroemer et al. 2009). Normally, it occurs during 
development and aging and is a homeostatic process that depletes unnecessary cell 
populations in tissues (Elmore 2007). Apoptosis can be induced by a multitude of different 
stimuli like e.g. exposure to ultraviolet light (Dunkern et al. 2001) or chemical substances 
(Zhang et al. 2000). In both cases, apoptosis is usually mediated in a p53-dependent way 
(Nayak and Cooper 2012). Apoptosis can also be triggered by external signalling molecules 
through death receptor stimulation (Yurchenko et al. 2012). 
The process of apoptosis is well defined and can be separated into early and late events. 
Early morphological events in apoptotic cell death include cell shrinkage and pyknosis (Kerr 
et al. 1972), which are both visible under the light microscope. Pyknosis is greek and means 
“to condense”, thus meaning an irreversible condensation of chromatin in the nucleus. 
Membrane inversion and the resulting exposition of phosphatidylserine on the outer cell 
surface is also a hallmark of early apoptosis (Taylor et al. 2008). At the same time, these 
externalised phosphatidylserines also serve as an “eat me signal” that causes the cell to be 
recognised and subjected to phagocytosis by macrophages (Fadok et al. 1992). A late event 
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in apoptosis is the fragmentation of DNA into oligonucleosomal fragments (Wyllie et al. 1980; 
Wyllie et al. 1984). 
In order to measure apoptotic cell death, these processes can be used to determine the 
amount and the dynamic of on-going apoptosis. The importance of tightly regulated 
apoptosis can be observed via its absence: If apoptosis is impaired, tumor growth increases 
(Ewald et al. 2011; Ivanov and Ronai 2000). Moreover, apoptosis is vital in keeping 
autoimmunity in check (Nagata et al. 2010). Interestingly, too much apoptosis or defects in 
engulfment of apoptotic bodies can result in autoimmunity as well (Nagata et al. 2010). Thus, 
a well-balanced apoptotic machinery is vital to an organism. In order to estimate the impact 
of apoptosis in the context of negative selection in the thymus, it was shown by the use of 
transgenic mice that two thirds of positively selected thymocytes in these mice were 
subjected to negative selection (van Meerwijk et al. 1997; Laufer et al. 1999). The majority of 
these positively selected T cells are usually deleted during maturation and are potentially 
autoreactive, which can lead to severe autoimmune diseases (Lamhamedi-Cherradi et al. 
2003). 
 
1.2.2 Caspases 
Caspases are the central components of apoptosis (Shi 2002). They are named because of 
their function as cysteine proteases, since they cleave their substrates following an Aspartate 
residue (Alnemri et al. 1996). Caspases are a family of conserved proteases, which exert 
various different functions and can by these means be separated into 3 different subgroups, 
namely the inflammatory, the initiator and the executioner caspases (Denault and Salvesen 
2002). All caspases do have in common that they are synthesised as a catalytically inactive 
pro-enzymatic form (zymogen) (Riedl and Shi 2004). Caspases have been reported to play a 
role in species ranging from yeast to men (Madeo et al. 2002; Kumar and Doumanis 2000; 
Ahmad et al. 1997). The inflammatory caspases 1, 4, 5, 11, 12 and 14 are mainly important 
for the proteolytic cleavage of inflammatory cytokines including IL-1β and IL-18 (Denault and 
Salvesen 2002). 
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Apoptotic caspases are mainly responsible for the regulation of apoptosis and are divided 
into two subgroups, namely initiator and effector caspases (Riedl and Shi 2004). The initiator 
caspases consist of caspase 2, 8, 9, and 10. They are characterized by two distinct subunits: 
the large (~p20) and the small (~p10) subunit (Riedl and Shi 2004). Initiator caspases have a 
large pro-domain, which is typically needed for protein-protein interactions (Taylor et al. 
2008). The activation of these caspases takes place by dimerization of multi-protein 
complexes via the Death Effector Domain (DED) for caspase 8 and 10 or via the Caspase 
Activating Recruitment Domain (CARD) for caspase 2 and 9 (Boatright et al. 2003). 
 
Figure 7: Schematic overview of the two different types of apoptotic caspases and the 
inflammatory ones, their function and structure.  
Caspases are separated into three different subgroups according to their function: Effector caspases, 
initiator caspases and inflammatory caspases. Depicted are the different caspases, their classification 
and their composition. Modified according to (Taylor et al. 2008). 
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The effector caspases form the second group, which comprise caspase 3, 6 and 7. These 
caspases are located in the cytoplasm in an already dimerised form and only need to be 
cleaved by the initiator caspases (Riedl and Shi 2004). After being cleaved, the active 
catalytic centre is accessible and the caspases proteolytically cleave a broad spectrum of 
cellular targets, ultimately leading to cell death (Salvesen and Abrams 2004). 
1.2.3 Regulation and molecular events in apoptosis 
Two major pathways are known to act during apoptosis and are activated depending on the 
origin of the death stimulus, namely the extrinsic and the intrinsic pathway (Riedl and Shi 
2004). The binding of an extracellular death ligand to its cell surface receptor activates the 
extrinsic, also called receptor-mediated apoptosis pathway (Wajant 2002). The probably 
best-studied example here is the binding of the CD95L/ FasL to its receptor, the 
CD95/Fas/Apo-1 (Nagata 1999). CD95 is a member of the tumor necrosis factor (TNF) 
superfamily of receptors and its main function is the induction of apoptosis, although other 
functional roles begin to emerge (Wajant 2002). CD95 receptors form pre-associated 
homodimers on the cell surface upon expression (Siegel 2000; Papoff et al. 1999). After 
activation of the CD95 receptor, the death-inducing signalling complex (DISC) is formed 
which comprise trimerized CD95, FADD and caspase 8 (Kischkel et al. 1995). Due to its 
death domain (DD), activated CD95 is able to bind the Fas-associated DD containing protein 
(FADD) (Chinnaiyan et al. 1995; Boldin et al. 1995). FADD itself also contains another 
protein-protein interaction domain, the death effector domain or DED. By means of this, it 
can recruit certain caspases e.g. caspase 8, which also contains a DED domain (Scaffidi et 
al. 1997). These two proteins together form the key components of the DISC, as caspase 8, 
in high concentrations, is believed to be able to autoproteolytically cleave and thereby 
activate itself (Medema et al. 1997; Salvesen and Dixit 1999). Subsequently, the initiator 
caspase 8 cleaves and activates the effector caspase 3, which ultimately leads to cell death 
(Fig.8) (Peter and Krammer 2003). 
The intrinsic apoptotic pathway is generally triggered by death stimuli that are sensed from 
within the cell. Examples of these stimuli are oncogene activation, radiation, toxins, free 
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radicals and DNA damage and its inactivation is considered an indicator of cancer (Hanahan 
and Weinberg 2000).  
The pathway starts with the so-called BH3-only proteins (Taylor et al. 2008). These normally 
inactive proteins become active under the various stresses described earlier. BH3-only 
proteins (BAD, BIK, BID, HRK, BIM, BMF, NOXA and PUMA) have a conserved BH3 domain 
that can bind and thereby inhibit the anti-apoptotic potential of the BCL-2 proteins (BCL-2, 
BCL-XL, BCL-W, A1A and MCL1) (Taylor et al. 2008; Youle and Strasser 2008). Thus, the 
pro-apoptotic BCL-2 family members BAX and BAK are no longer inhibited themselves and 
can induce the mitochondrial outer membrane permeabilisation (MOMP) (Wei et al. 2001; 
Tait and Green 2010). As a consequence of this disruption of the mitochondrial outer 
membrane integrity, the membrane potential gets lost and therefore pro-apoptotic proteins 
from the intermembrane space are released into the cytosol (Saelens et al. 2004; Elmore 
2007). Of the pro-apoptotic molecules released after MOMP, cytochrome c is the best 
investigated one (Wang 2001). Upon release from the outer mitochondrial membrane 
(OOM), cytochrome c binds to APAF1 and thus leads to the assembly of the so-called 
apoptosome, a heptameric protein ring (Fig. 8). In turn, the APAF1- cytochrome c complex 
can bind and activate pro-caspase 9 and induce apoptotic cell death (Wang 2001; Shi 2006; 
Youle and Strasser 2008). 
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Figure 8: Schematic overview of extrinsic and intrinsic cell death:  
The death receptor for the extrinsic pathway, as well as the most prominent BCL-2 family members 
are depicted. The relationship of the two pathways in respect to caspase activation and ultimately cell 
death are shown. Modified according to (Maiuri et al. 2007). 
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initiator caspases to induce cell death (Samraj et al. 2006; Scaffidi et al. 1998). In order to 
activate caspase 3 properly, type II cells therefore need the intrinsic apoptosis pathway in 
addition to the extrinsic one. 
 
1.2.4 Apoptosis in negative selection of T cells in the thymus 
It is mandatory for an intact immune system to be able to distinguish between self and 
non-self. In this way, potentially harmful foreign organisms can be eliminated without posing 
a threat to the body. Along these lines, the immune system must tolerate self-antigens but 
has to be able to recognise degenerated tissue, thus cancer, and eliminate it before it 
spreads (Chen et al. 1993). Non-pathogenic foreign antigens, e.g. food antigens, also must 
be prevented from triggering an immune response. The cornerstone of an intact immune 
system is therefore the correct priming of immune cells. Lymphocytes are the key players in 
the body that mediate this balance between inflammatory response and tolerance (Hogquist 
et al. 2005). The thymus is the organ in which lymphocytes, thus the name T cell, mature and 
it is also the place where T cells are confronted with self-antigens to convey tolerance 
(Hogquist et al. 2005). Hematopoietic stem cells from the bone marrow are the progenitor 
cells of lymphocytes and these seed the thymus and undergo maturation there (Palmer 
2003). The thymus is comprised of two anatomically different regions: The outer region or 
cortex, which contains immature thymocytes and the inner region or medulla, which holds 
mature thymocytes (Petrie 2002). 
One of the earliest steps during thymocyte development is the expression of an antigen 
receptor or αβ T cell receptor (TCR) (Starr et al. 2003; Schatz and Ji 2011). T cells without 
such a receptor are so-called double-negative (DN) thymocytes, as they are DN for the 
co-receptors of the TCR, cluster of differentiation 4 and 8 (CD4 and CD8). DN thymocytes 
form a pre-T cell receptor, which is characterised by a β chain and a pre-T cell α receptor 
chain (Palmer 2003). This pre-α-TCR chain could be identified as a crucial component of 
thymocyte development (Fehling et al. 1995). During the maturation process, the T cells pass 
through several developmental DN steps, characterised by the expression of the cell surface 
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markers CD44 and CD25 (Lind et al. 2001). During these developmental steps, the antigen 
receptor evolves (Starr et al. 2003). This is characterised by the antigen receptor 
re-arrangement. This re-arrangement is a stochastic process, in which the genes that encode 
the receptor are re-combined as arrays of variable (V), diversity (D) and joining (J) gene 
segments. The RAG protein complexes (RAG1 and RAG2) introduce a double-strand brake 
in the DNA at specific recombination signal sequences (RSSs), flanking each V, D and J 
gene segment (Schatz and Ji 2011). As a result, a large variety of different, specific 
receptors are generated (Davis and Bjorkman 1988). From a mathematical point of view, up 
to 3x1011 different combinations are possible. After V(D)J recombination, the thymocytes are 
called double positive (DP), as they have become DP for the expression of the surface 
proteins CD4 and CD8. These double positive thymocytes can undergo three different cell 
fates: positive selection, negative selection and death by neglect (Starr et al. 2003). Around 
90% of the generated TCRs are not able to receive a survival signal via MHC from an 
antigen presenting cell (APC) and therefore the thymocytes die. This process is called death 
by neglect (Zilberman et al. 1999). The remaining 10% of the thymocytes can interact with an 
MHC. For these, two different outcomes are possible: On the one hand the TCR interacts 
with an MHC molecule with a rather low affinity, which results in positive selection of these 
thymocytes and subsequent differentiation into either CD8+ T cells or CD4+ T cells, 
depending on the MHC molecule (MHC class I or MHC class II peptide) (Fig. 9) (Hedrick 
2012). 
On the other hand, the thymocytes can interact with an MHC molecule with a high affinity. 
Here, the thymocytes recognise self-antigen very efficiently and thus are deleted by 
apoptosis induction. This process is called negative selection (Starr et al. 2003; Palmer 2003; 
Stritesky et al. 2012). The orphan steroide receptor Nur77, an intracellular transcription 
factor, serves as a well-accepted marker for negative selection (Calnan et al. 1995; et al. 
2003). 
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Figure 9: Thymocyte development in the thymus.  
Depicted are the different stages of thymocyte development ranging from double negative (DN) to 
single positive (SP), their respective cell surface markers and their selection processes plotted against 
their location in the thymus. 
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al. 2002). A loss of Aire leads to the severe autoimmune polyendocrine syndrome type 1 
(APECED) in men (Holler et al. 2000; Peterson et al. 1998; Vercammen et al. 1998). 
Of note, some bacteria and viruses have boarded these mechanisms of antigen recognition 
in order to camouflage themselves from the immune system. In this regard, superantigens 
(SAgs) play an important role. SAgs are proteins of microbial origin and stimulate T cells via 
interaction with the Vβ domain of the TCR. An example of such a SAg is the mouse 
mammary tumor virus (MMTV), is well characterized.  
B cells present the SAg to indicidual T cell subsets upon MMTC infection. This leads to a T-B 
cell interaction, which in turn makes sure that infected B cells are preferentially clonally 
expanded. Along these lines, some of these B cells differentiate into long-lived memory cells, 
ascertaining a stable MMTV infection that can be passed on to offspring via maternal milk 
(Kroemer et al. 2009; Acha-Orbea and MacDonald 1995; Scherer et al. 1993). 
 
1.3 The crosstalk between apoptosis and autophagy 
1.3.1 General considerations about the interaction of apoptosis and autophagy 
The idea of crosstalk existing between apoptosis and autophagy is relatively new, most likely 
due to the general understanding of these two distinct processes: Apoptosis is a – not to say 
the – cell death mechanism and a huge number of publications in the 1990s elucidated many 
important aspects (Thorburn 2007). In contrast, the understanding of autophagy is still 
incomplete in many ways and only recent publications aided in the further understanding of 
its functions. Autophagy is nowadays believed to be both – a cell death and a cell survival 
mechanism through its cytoprotective function (chapter 1.1) (Levine and Yuan 2005; 
Baehrecke 2005; Gozuacik and Kimchi 2007). 
Two major crosstalk models between apoptosis and autophagy could be experimentally 
validated: One is the cooperation between the two, which leads to cell death. The other is the 
antagonism between autophagy and apoptosis, where autophagy blocks apoptosis 
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(Eisenberg-Lerner et al. 2009). The principal concept of the first model is either a backup 
mechanism where in the event one fails the other can fill the void, or a cooperative manner. 
Regardless of the mode of action, the ultimate goal remains the same: the death of the cell. 
The fact that one pathway is able to take over for both, points towards a coordination at the 
molecular level. This crosstalk could be shown for a multitude of different apoptosis-inducing 
agents, such as the activation of the TRAIL receptor-2 in cancer cells, ceramide in breast 
and colon carcinoma and with vitamin K2 in HL-60 cells (Park et al. 2007; Pattingre et al. 
2009; Yokoyama et al. 2008). A study where CD4+ T lymphocytes were infected with HIV, 
showed that autophagy enhances caspase-dependent cell death and as a result the blocking 
of autophagy led to the inhibition of apoptosis (Espert et al. 2006). Interestingly, the knock 
down of Atg7 or Beclin 1 suppressed caspase activation, whereas the inhibition of apoptosis 
accelerated autophagy induction. These two facts imply that autophagy acts upstream and 
independently of apoptosis (Eisenberg-Lerner et al. 2009). Autophagy intersects with the 
intrinsic pathway as well, as it can degrade catalase resulting in reactive oxygen species 
(ROS) accumulation and subsequent mitochondrial outer membrane permeabilization 
(MOMP) (Yu et al. 2006). This could be inhibited by the knockdown of Atg7 and Atg8 (Yu et 
al. 2006). All of the studies commonly showed that activation of apoptosis, autophagy or both 
together result in the killing of the cell, whether it being in a cooperative or in a mutually 
exclusive manner. 
The second concept is the antagonistic model, where in principal apoptosis and autophagy 
are two discrete mechanisms that counteract one another. In this case autophagy is a cell 
survival mechanism, opposing the cell death mediated by apoptosis. The classical autophagy 
stimulus is starvation and a number of groups proved that an intact autophagosomal 
apparatus is essential for surviving periods of nutrient reduction, both in vitro (Boya et al. 
2005; Lum et al. 2005) and in vivo (Komatsu et al. 2005; Kuma et al. 2004). As opposed to 
the role of apoptosis induction through catalase degradation (Yu et al. 2006), autophagy can 
also play a contradictory role in the intrinsic apoptosis pathway, namely through mitophagy 
(Novak 2012). During mitophagy, autophagy scavenges depolarised mitochondria and 
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prevents release of intracellular ROS and other pro-apoptotic molecules like cytochrome c 
and Diablo (Kubli and Gustafsson 2012; Kim et al. 2007). Taken together, the examples 
given demonstrate that autophagy can also be a potent inhibitor of cell death and is therefore 
an antagonist of apoptosis. 
Of note, a third mode of action has been proposed in which autophagy enables apoptosis by 
providing sufficient levels of adenosine tri-phosphate (ATP) for its execution. The authors 
could show that a lack of autophagy-relevant proteins, such as Atg5, results in decreased 
phosphatidylserine exposure at the surface of apoptotic cells and reduced membrane 
blebbing (Inbal et al. 2002; Qu et al. 2007). The major hallmark of this proposed “enabling 
mechanism” is the lack of other autophagy-relevant cross talk events. How this is regulated 
and what mechanisms could be involved remains to be elucidated. 
 
1.3.2 Beclin 1 acts as a hub connecting autophagy and intrinsic apoptosis 
Beclin 1 could be identified via a yeast two-hybrid screen as an interaction partner of Bcl-2, 
the namesake protein of the Bcl-2 family of apoptosis-regulating proteins (Liang et al. 1998). 
Later studies demonstrated that Beclin 1 is a BH-3 only protein that interacts with other Bcl-2 
family members, namely Bcl-xL, Bcl-w, Bim and Mcl-1 (Wirawan et al. 2012; Luo et al. 2012). 
This interaction is mediated through the BH3 domain of Beclin 1, and mutations in this 
domain result in a loss of interaction (Feng et al. 2007; Maiuri et al. 2007; Oberstein et al. 
2007). Interestingly, Beclin 1 does not interact with other pro-apoptotic BH3 only proteins 
(Feng et al. 2007; Oberstein et al. 2007; Gordy and He 2012). Along these lines, only 
ER-localised Bcl-2 family members are able to inhibit starvation-induced autophagy by 
interaction with Beclin 1 (Pattingre et al. 2005; Maiuri et al. 2007). Recently, Chang and 
colleagues demonstrated that this interaction between Beclin 1 and Bcl-2 interaction at the 
ER is stabilised by the nutrient-deprivation autophagy factor-1 (NAF-1) (Chang et al. 2010). 
Via an siRNA knockdown of NAF1, the authors could also show the disruption of the 
Beclin 1/Bcl-2 complex that led to the induction of autophagy. 
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Assuming a more physiological setting, for instance intracellular stress due to starvation, 
Beclin 1 must disassociate from Bcl-2 and Bcl-xL in order to promote autophagy (Pattingre et 
al. 2005). Although numerous mechanisms have been described so far that involve proteins 
such as DAPK, HMGB1 or other BH3 only proteins (Luo and Rubinsztein 2007; Maiuri et al. 
2007; Zalckvar et al. 2009; Zalckvar et al. 2009; Kang et al. 2010; Tang et al. 2010), Bcl-2 
phosphorylation by JNK plays a pivotal role in the initiation of autophagy (Wei et al. 2008). 
The authors could demonstrate that JNK deficiency leads to a loss of starvation-induced 
autophagy and using a gain-of-function approach they demonstrated that autophagy is 
activated even under nutrient-rich conditions. This was accomplished by overexpression of a 
constitutively active JNK1-mutant. Interestingly, The Beclin 1/Bcl-2 complex is also sensitive 
to both Bad and Bax (Zhu et al. 2010; Maiuri et al. 2007). Both of these proteins are able to 
disassociate Bcl-2 from Beclin 1, but with very different outcomes. Bad removes the 
inhibitory effect of Bcl-2 and promotes autophagy, whereas Bax overexpression reduces 
autophagy (Maiuri et al. 2007; Luo and Rubinsztein 2010). However, the authors could prove 
that this reduction is not due to the disruption of the Beclin 1/Bcl-2 complex by Bax, but 
rather due to Beclin 1 being targeted for caspase cleavage (Luo and Rubinsztein 2010). 
Therefore, autophagy initiation together with the PI3K hVps34 was not occurring. 
In contrast to the implications of the role of Beclin 1 in autophagy discussed above, the 
Beclin 1/hVps34 complex is not an essential component of autophagy in general. To look at 
this fact, the situation in T lymphocytes is best investigated. Although CD4+ Beclin 1-/- T cells 
show largely abolished autophagy and increased apoptosis, LC3 puncta formation could still 
be observed (Arsov et al. 2011; Kovacs et al. 2011). Along these lines, it was established 
that the Beclin 1-deficient T lymphocytes proliferated normally (Arsov et al. 2011). Another 
study was recently able to demonstrate that autophagy levels in T lymphocytes deficient for 
Vps34 are completely normal, although the T lymphocytes were clearly affected by the loss 
of Vps34 (Mcleod et al. 2011). Taken together, the data currently available do not allow for a 
comprehensive understanding of the crosstalk between apoptosis and autophagy mediated 
by Beclin 1. 
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1.3.3 Caspase-dependent autophagy regulation 
Bcl-2 family members are not the only apoptosis-related proteins that are involved in 
autophagy. Caspases, essential components of both the extrinsic and the intrinsic apoptosis 
pathway have recently been found to play a role in autophagy as well. 
The first work that was able to demonstrate the direct effect of a protein very similar in 
function to a caspase on another protein involved in autophagy was by Yousefi and 
colleagues (Yousefi et al. 2006). Although caspases and calpains differ in their cleavage-site 
specificity, they are quite similar among each other and a large number of proteins were 
identified that are equally susceptible to both (K. Wang 2000). They showed the cleavage of 
Atg5 by calpain 1 and calpain 2 in human neutrophils that were undergoing apoptosis 
(Yousefi et al. 2006). Interestingly, an amino-terminal cleavage product could be detected 
that translocated to the mitochondria where it associated with Bcl-xL and thus induced 
cytochrome c release. Additionally, the overexpression of this cleavage product alone was 
sufficient to induce apoptosis (Yousefi et al. 2006). This finding was even more important 
when considering the fact that the overexpression of LC3 alone did not change apoptotic 
events, thus demonstrating that rather than autophagy as a whole, solely the cleavage 
product of Atg5 influenced apoptosis. 
Later on, Beclin 1 was also identified as a target of cleavage by caspases. The identified 
caspases differed, depending on the experimental systems and cell types investigated. 
Caspases 3, 6, 9 and 10 have all been found to interact with Beclin 1 (Luo and Rubinsztein 
2010; Cho et al. 2009; Wirawan et al. 2010; Zhu et al. 2010; Li et al. 2011; Rohn et al. 2011). 
Interestingly, one of these studies in Hela cells showed that the cleavage of Beclin 1 plays a 
role in autophagy, as non-cleavable Beclin 1 mutants were not able to increase 
autophagosome formation upon starvation (Zhu et al. 2010). In summary, these results prove 
the existence of a complex network between autophagy and apoptosis. The cleavage 
products of autophagosome-associated proteins seem to play a pivotal role not only in 
apoptosis, but also in autophagy by itself. The work introduced so far reveals only a small 
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part of this intricate network, a lot of work needs to be done to elucidate the exact molecular 
details that are still missing. 
 
1.3.4 The interplay between the extrinsic apoptosis pathway and autophagy 
As mentioned in section 1.2.3, extrinsic apoptosis is mediated by a death-inducing signalling 
complex (DISC) that is initiated by the triggering of an external cell surface receptor (Kischkel 
et al. 1995). Caspase 8 plays an important role in this DISC: When its pro-active form is 
cleaved, active caspase 8 is released and activates the effector caspase 3 (Peter and 
Krammer 2003). The FLICE inhibitory protein (c-FLIP) can interact with caspase 8 at the 
DISC and either inhibits or enhances caspase 8 activation (Thome and Tschopp 2001; 
Wilson et al. 2009; Ewald et al. 2011; Ueffing et al. 2008). Caspase 8-deficiency could be 
linked to excessive autophagy in fibroblasts, macrophages and T cells (Bell et al. 2008; Yu et 
al. 2004). Furthermore, a mutant of the Fas-associated protein with death domain (FADD) 
that did not contain a death effector domain (DED), was unable to mediate an interaction with 
either caspase 8 nor c-FLIP and showed the same phenotype (Bell et al. 2008; Thorburn et 
al. 2005). A recent study was able to provide an important link between the DISC and 
autophagy: FADD interacts with Atg5 through its DD (Pyo et al. 2005). Interestingly, a lack of 
FADD did not affect autophagosome formation, but rather rescued the increased cell death 
that resulted from Atg5. Therefore, the interaction of FADD with Atg5 seems to regulate 
apoptosis, not autophagy. 
Recently, it could be proven that caspase 8 activation is not only restricted to the DISC, but 
rather that caspase 8 co-localises with Atg5, LC3 and p62 (Young et al. 2012). Moreover, 
FADD could be found on Atg5/Atg16L and LC3-positive cytosolic spots, indicating that FADD 
is also located on the autophagosomal membrane. The authors therefore concluded that the 
autophagosomal membrane serves as a platform for an intracellular DISC (iDISC) that 
recruits caspase 8 in order to initiate the intrinsic caspase 8/3 cascade (Young et al. 2012). 
However, c-FLIP was not found to be a part of this proposed iDISC complex, although it was 
identified as an important inhibitor of autophagy (Lee et al. 2009). In the same study, c-FLIPS 
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and cFLIPL were also associated with the inhibition of rapamycin-induced autophagy (Lee et 
al. 2009). This phenotype could be rescued with a siRNA-mediated knockdown of c-FLIP. 
Interestingly, the authors could demonstrate that the anti-autophagic function of FLIP was 
independent of its anti-apoptotic function, since mutants that were unable to bind to FADD or 
TRAF2 and could not activate NF-κB could still inhibit autophagy. 
Taken together, these studies clearly demonstrate that proteins that exhibit a specific 
function in DISC-mediated apoptosis have a different and independent function in autophagy. 
This is also true for autophagy-associated proteins and their cleavage products, which exert 
an all-together different function in the context of apoptosis. Importantly, many of the proteins 
that are associated with either apoptosis or autophagy seem to have dual roles and clearly 
demonstrate the close interaction between these two important pathways. 
 
1.4 The Gadd45 family 
1.4.1 General considerations about the Gadd45 family 
The Growth Arrest and DNA damage-inducible gene 45 (Gadd45) family is comprised of 3 
different genes, namely Gadd45a, Gadd45b and Gadd45g. As the name of the family 
implies, Gadd45 proteins have been implicated in cellular functions such as DNA repair 
(Vairapandi et al. 1996; Smith et al. 1994; Smith et al. 2000), cell survival (Smith et al. 2000; 
Gupta et al. 2006; Smith et al. 1996; De Smaele et al. 2001; Amanullah et al. 2003; Gupta et 
al. 2005), senescence (Tront et al. 2006), apoptosis (Takekawa and Saito 1998; 
Selvakumaran et al. 1994; Zhang et al. 2001; Yoo et al. 2003; Vairapandi et al. 2000; Azam 
et al. 2001; Harkin et al. 1999; Kojima et al. 1999; Hildesheim et al. 2002) and tumor 
development in vivo (Tront et al. 2006; Hollander et al. 1999). Gadd45 (Gadd45a), Myd118 
(Gadd45b) and CR6 (Gadd45g), collectively referred to as the Gadd45 gene family, encode 
for small (18 kDa), evolutionary conserved proteins, which are highly acidic (pI= 4.0-4.2) and 
have a certain degree of similarity with each other (~55%) (Tamura et al. 2012; Liebermann 
and Hoffman 2008). The proteins exhibit their biological function via direct protein-protein 
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interaction (Tamura et al. 2012). The Gadd45 proteins are localised in the nucleus and the 
cytoplasm and are present at relatively low levels in normal, unstimulated cells (Vairapandi et 
al. 2002; Zhang et al. 1999; Abdollahi et al. 1991). Upon environmental stresses such as UV 
and γ irradiation or anisomycin treatment, the Gadd45 protein family members are rapidly 
induced (Takekawa and Saito 1998). In general, Gadd45 proteins are highly expressed 
during the G1 phase of the cell cycle and are significantly reduced during the S phase 
(Kearsey et al. 1995). In addition, the different Gadd45 family members are differentially 
expressed in distinct murine tissues (Table 1). 
Tissue Gadd45α  Gadd45β  Gadd45γ  
Skeletal muscle + +/- + 
Kidney + - + 
Liver +/- +/- + 
Heart +/- - - 
Brain +/- - - 
Spleen +/- - - 
Lung +/- + - 
Testis - - - 
 
Table 1: Expression profile of the Gadd45 family in mouse tissue.  
+ = high expression, +/- = moderate expression, - = low expression. Table set according to (Tattoli et 
al. 2012; Zhang et al. 1999; Knodler and Celli 2011). 
 
Gadd45α was the first of the three proteins that was identified, thus the name. It was 
detected by the screening of a cDNA library of increased transcripts after ultraviolet (UV) 
irradiation of chinese hamster (CHO) cells (Fornace et al. 1988; Fornace et al. 1989). 
Gadd45α is also a target of p53 (Selvakumaran et al. 1994; Guillouf et al. 1995; Kastan et al. 
1992). Gadd45β was transiently induced by interleukin-6 (IL-6) treatment in myeloid 
leukaemia cell lines (Abdollahi et al. 1991). It was also identified by TGF-β stimulation in 
hepatocytes and myeloid leukaemia cells and by T cell receptor (TCR) stimulation (Lu et al. 
2001; Lu et al. 2004; Yoo et al. 2003; Selvakumaran et al. 1994; Schmitz et al. 2003). 
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Gadd45γ, also known as CR6, OIG37 or GRP17 was originally identified as an IL-2 inducible 
gene (Beadling et al. 1993; Nakayama et al. 1999; Kojima et al. 1999). 
 
1.4.2 Protein-protein interaction and known binding partners 
As mentioned earlier, Gadd45 proteins exert their biological function via a direct protein-
protein interaction. How exactly this interaction is mediated is the focus of current research. 
For Gadd45α and Gadd45γ, the three-dimensional structure could be elucidated via nuclear 
magnetic resonance (NMR) and crystallography (Sánchez et al. 2008; Schrag et al. 2008). 
These two studies could show, that the two proteins share similar secondary structures, both 
having 5 α-helices and 5 β-sheets. The high levels of homology suggest similar functions, 
and indeed both proteins interact with overlapping interaction partners, including: CDK1 
(Zhan et al. 1999; Jin et al. 2000; Yang et al. 2000), PCNA (Hall et al. 1995; Vairapandi et al. 
2000; Azam et al. 2001), p21 (Yang et al. 2000; Zhao et al. 2000) and MTK1 (Takekawa and 
Saito 1998). All of these proteins are involved in cell cycle control, cell survival, senescence 
and tumor development. 
Interestingly, Gadd45 proteins can interact with each other and form homo- or hetero-dimers. 
With the help of mutational and crystallography analyses, several regions crucial for the 
oligomerisation of Gadd45 proteins could be identified (Schrag et al. 2008). Moreover, some 
of these oligomerisation-impaired mutants showed a reduced interaction with p21, CDK1 and 
PCNA (Kovalsky et al. 2001; Schrag et al. 2008; Yang et al. 2000). Up to now, the structure 
of Gadd45β has not been resolved. However, as Gadd45β also interacts with a number of 
similar proteins, e.g. PCNA and p21 (Vairapandi et al. 1996; Smith et al. 1994; Smith et al. 
2000; Vairapandi et al. 2000; Azam et al. 2001), and was shown to interact with Gadd45α 
(Kovalsky et al. 2001), it seems reasonable to assume an analogue mode of interaction. 
Additionally, a study that analysed the interaction of Gadd45β and MAP2K7, predicted a 
three-dimensional structure of Gadd45β and a similar mode of action as for both other 
Gadd45 proteins (Papa et al. 2007). 
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Interestingly, as Gadd45 proteins seem to exert similar functions and have a large pool of 
interaction partners in common. A redundant function, at least in part, was found by different 
groups (Liu et al. 2005): Young Gadd45β-/- and Gadd45γ-/- mice did not develope 
spontaneous signs of autoimmunity. However this was different when they reached a high 
age or were challenged with an induced autoimmune syndrome like experimental 
autoimmune encephalomyelitis (EAE) (Lu 2006). In contrast to this, mice deficient for both 
Gadd45 proteins show severe autoimmune lymphoproliferative syndrome and systemic lupus 
erythematosus. 
 
1.4.3 Gadd45 proteins and cell cycle control 
Ordinarily, the cell cycle is defined by the G1, S, G2 and M phases and is well regulated. 
This process is controlled in part but not exclusively by cyclin-dependent kinases (CDK) 
(Vermeulen et al. 2003). Between the G2 and the M phase, the CDK1/Cyclin1 B1 complex is 
a major checkpoint (Nurse 1996). The Gadd45 protein family members interact directly with 
CDK1, but not with cyclin1 B1 (Zhan et al. 1999). In this regard, the kinase activity of the 
whole complex is inhibited. Interestingly, Gadd45α and Gadd45β disrupt the whole complex, 
whereas Gadd45γ inhibits the complex without disrupting it (Vairapandi et al. 2002). 
Additionally, all three Gadd45 proteins interact with p21, which activates the G1/S checkpoint 
(Zhang et al. 1993; Vairapandi et al. 1996; Fan et al. 1999). As a consequence, the Gadd45 
proteins indirectly lead to a cell cycle arrest (Zhang et al. 1993; Vairapandi et al. 1996; Fan et 
al. 1999). 
 
1.4.4 Gadd45 proteins and MAPK signalling 
In order to be able to process extracellular stimulations such as e.g. stresses, cytokines or 
growth factors, cells needed to develop mechanisms to receive those signals, transmit them 
and mount an appropriate response. These signal transduction events heavily rely on 
post-translational modifications of proteins, a key event of which is phosphorylation. 
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MAPK pathways are comprised of a three-tier kinase module in which a MAPK is activated 
upon phosphorylation by a mitogen-activated protein kinase kinase (MAPKK), which in turn is 
activated when phosphorylated by a MAPKKK (Dhillon et al. 2007). MAPKKK are serine-
threonine kinases, which receive their activation signal via e.g. receptors on the cell surface. 
Their substrates, the MAPKK, which are threonine-tyrosine kinases phosphorylate the 
MAPK, which are serine-threonine kinases (Hagemann and Blank 2001). 
To date, at least four important subfamilies of the MAPK could be distinguished: the 
extracellular signal-regulated kinases (ERK1/2), ERK5, the c-Jun amino terminal kinases 
(JNK1-3) and the p38 kinases (p38α, β and γ) (Han et al. 1994; Lee et al. 1994; Rouse et al. 
1994; Freshney et al. 1994). 
All three Gadd45 proteins directly interact with the upstream MAPKK kinase MTK1/MEKK4 in 
response to environmental stress (Takekawa and Saito 1998). This interaction results in a 
downstream activation of p38/JNK and the subsequent initiation of apoptosis (Takekawa and 
Saito 1998). For Gadd45β this interaction could be elucidated in great detail. Its N-terminal 
amino acid residues (13-132) bind to the auto-inhibitory domain of MTK1, and lead to a 
conformational change, resulting in dimerisation of the kinase, autophosphorylation and 
activation of the kinase domain (Takekawa and Saito 1998; Mita et al. 2002; Miyake et al. 
2007). Gadd45α could also be identified as a direct interaction partner of the p38 MAPK 
(Bulavin et al. 2003).  
p38 is directly activated via the MAPKKs, MKK3 and MKK6 (Enslen et al. 1998), whereas 
JNK gets phosphorylated via MKK4 or MKK7 (Haeusgen et al. 2011). Both MAPKs p38 and 
JNK have been reported to play a role in apoptosis, cell survival and autophagy (Xu et al. 
2011; Kyriakis 2001; Keil et al. 2012; Chou et al. 2001). Along these lines, it was shown that 
Gadd45β directly interacts with MKK7/JNKK2, but not with MKK4/JNKK1, the other JNK 
kinase (Papa et al. 2004). Here, Gadd45β directly binds to MKK7/JNKK2 and thereby blocks 
its catalytic activity. Through this mechanism, JNK can no longer be phosphorylated and 
ultimately, apoptosis induction is inhibited (Papa et al. 2004). 
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Obviously, the interaction of the different MAPKs with the MAPKKs and the MAPKKKs needs 
to be tightly regulated in order to maintain cellular functionality. To this end, the 
phosphorylation events among each other are influenced by at least two independent 
methods: On the one hand the MAPKs need to be brought into close proximity to each other 
to allow for the phosphorylation event to take place. This is ascertained by scaffold proteins, 
which provide an insulated physical conduit, through which signals form the respective 
MAPK can be transmitted to the appropriate spatiotemporal cellular loci (Dhanasekaran et al. 
2007). On the other hand, a so-called domain for versatile docking (DVD) at the MAPKK can 
determine specificity of the MAP3K docking partner (Takekawa et al. 2005). Additionally, a 
docking site in a non-catalytic region in ERK, p38 and JNK was identified which serves as an 
interaction domain for their corresponding MAPKKs (Tanoue et al. 2000; Tanoue et al. 2001). 
These common docking sites (CDs) increase the efficiency of their respective enzymatic 
activity and in this way represent another way of MAPK regulation (Tanoue et al. 2000). 
1.4.5 Gadd45 proteins in apoptosis 
The Gadd45 protein family has been implicated in many signalling processes, in which a 
deregulation can lead to an increase in apoptosis. Of these, the interaction with the MAPK 
p38 and the indirect regulation of JNK through MKK7 are considered to be the best 
described (Papa et al. 2004). For example, Gadd45α-deficient mouse skin tissue and 
keratinocyte cell lines show a reduced p38, JNK and p53 activation and are resistant towards 
UV-induced apoptosis (Hildesheim et al. 2002). TGF-β-dependent apoptosis is delayed in 
Gadd45β-silenced myeloid leukaemia and pancreatic cancer cell lines and in primary mouse 
hepatocytes (Takekawa et al. 2002; Yoo et al. 2003; Selvakumaran et al. 1994). This 
TGF-β-induced apoptosis is dependent on Smad 2, 3 and 4 (Yoo et al. 2003). Moreover, 
Gadd45β is 72-fold up-regulated in a mouse model of negative selection in the thymus upon 
stimulation of the TCR with high affinity ligands (Schmitz et al. 2003). Interestingly, the pro-
apoptotic role of the Gadd45 proteins was not limited to the extrinsic apoptosis pathway, but 
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for Gadd45α could also be linked to Bax-mediated cytochrome c release into the cytoplasm 
in HeLa cells (Tong et al. 2005; Tamura et al. 2012). 
In contrast to these observations, bone marrow cells from Gadd45β-/- mice were more 
susceptible towards apoptotic stimuli such as UV- irradiation and cytotoxic chemicals like 
chemotherapeutics, VP-16 and daunorubicin (Gupta et al. 2006; Gupta et al. 2006; Gupta 
2003). Along these lines, Type1 T helper (TH1) cells in the synovial fluid of patients with 
rheumatoid arthritis express high levels of Gadd45β and are resistant to apoptosis (Du et al. 
2008). This enhanced apoptosis resistance could be abolished by RNAi silencing of 
Gadd45β. Its overexpression in fibroblasts also elevated the apoptosis resistance in those 
cells, but MEFs from Gadd45β-/- mice showed no susceptibility to Tumor necrosis factor-α 
(TNF-α)− mediated apoptosis and had no differences in JNK activity (Engelmann et al. 2008; 
Amanullah et al. 2003). Furthermore it was recently shown that the induction of the 
pro-apoptotic JNK cascade downstream of the Tumor necrosis factor receptor (TNFR) was 
significantly increased in Gadd45β-/- mice after partial liver hepatectomy (Papa et al. 2008). 
After a partial liver hepatectomy, NF-κB is induced to counter the effects of JNK activity by 
induction of target genes and to allow for regeneration. As Gadd45β is an NF-κB target gene 
(De Smaele et al. 2001; Papa et al. 2004), Papa and colleagues conclude that Gadd45β 
represses JNK activity in hepatocytes after TNFR activation in response to partial liver 
hepatectomy (Papa et al. 2008). The same group was earlier able to identify the mechanism 
by which Gadd45β impairs JNK activation. Gadd45β interacts with MKK7/JNKK2, which is a 
specific and essential activator of JNK (Papa et al. 2004; Tournier et al. 2001). In summary, 
Gadd45β controls the activation of JNK. 
 
1.4.6 Gadd45 proteins in methylation 
The process of DNA methylation is an epigenetic modification to silence genes, which is an 
important mechanism of gene regulation in vertebrates (Reik 2007). A study in Xenopus 
laevis could show a Gadd45α-dependency in the process of active DNA demethylation 
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(Barreto et al. 2007). They concluded that Gadd45α relieves epigenetic gene silencing by 
promoting DNA repair, which erases methylation marks. Additionally, a recent study in Danio 
rerio elucidated that demethylation levels were Gadd45-dependent. Overexpression of 
Gadd45α increased demethylation, while silencing of the Gadd45 gene family reduced it (Rai 
et al. 2008). Gadd45 proteins have numerous implications in active DNA demethylation: A 
recent publication shows that Gadd45a and Gadd45b were both induced during epidermal 
differentiation, probably because of their interaction with base excision repair (BER) and 
nucleotide excision repair (NER) DNA demethylase complexes (Sen et al. 2010). The same 
study revealed that increased Gadd45 expression induced premature differentiation of 
progenitors and inhibited their growth, both of which are hallmarks of demethylation activity 
(Sen et al. 2010). Moreover, enforced Gadd45 expression led to the same increase in 
muscle differentiation genes as the depletion of DNA demethyltransferase 1 (DNMT1) (Sen 
et al. 2010). Along these lines, another publication showed the same effect for adult 
neurogenesis through DNA demethylation. Proliferation of neuronal progenitors and dendritic 
growth of new-born neurons in the adult hippocampus was severely impaired in 
Gadd45β-deficient mice (Ma et al. 2009; Wu and Sun 2009). 
However, two different studies obtained contradictory results: Both groups showed that 
Gadd45α-deficiency did not have an impact on DNA demethylation (Engel et al. 2009; Jin et 
al. 2008). Thus, whether or not Gadd45a-deficiency has an impact on DNA demethylation is 
not clear yet. Interestingly, a group identified Gadd45β as a direct target of the forkhead box 
3 transcription factor (Foxp3) in an array approach in hybridoma cells (Marson et al. 2007). 
Foxp3 is the main transcription factor regulating the induction of regulatory T cells (Treg), a 
T cell subtype that has been shown to be a major contributor to peripheral tolerance 
(Sakaguchi et al. 1995). Here, the stability of so-called natural regulatory T cells (nTregs) is 
heavily dependent on the methylation status of a DNA region named the Treg-cell specific 
demethylated region (TSDR) (Huehn, Polansky, and Hamann 2009). It was shown that Treg 
stability is dependent on a demethylated TSDR/CNS2 (Floess et al. 2007; Polansky et al. 
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2008). Thus, there might be a connection between Treg stability and Gadd45β. Whether this 
possible connection is of any relevance needs to be further elucidated in the future. 
 
1.5 Aims 
The aim of this thesis was to determine the effect of Gadd45β on different cellular 
mechanisms: On the one hand on autophagy and on the other hand on apoptosis in the 
context of negative selection in the thymus. As described above, autophagy has numerous 
and different implications in cellular biology and immunity, therefore its regulation needs to 
be tightly controlled. Previous work on this topic showed evidence of a 
Gadd45β-MEKK4-p38-dependent phosphorylation of Atg5 (Keil 2008). However, the 
physiological consequences and the proof of an in vivo phosphorylation remained 
unresolved. Recent publications could already demonstrate the influence of MAPKs on 
autophagy-related proteins (Wei et al. 2008; Wang et al. 2009). Nevertheless, the 
interactions studied so far were limited to the initiation phase of autophagy. Therefore, 
previous results of research on the MAPKs-dependent post-translational modification of the 
autophagic flux make up one part of this thesis. 
On the other hand, Gadd45β was identified to be highly upregulated upon challenge of the 
TCR with high-affinity peptides in an in vivo model of negative selection (Schmitz et al. 
2003). Additionally, Gadd45β-deficient thymocytes were protected from apoptosis compared 
with wildtype thymocytes in a fetal thymic organ culture model (FTOCs) (data not shown). 
The known interaction of Gadd45β with the MAPKKK MEKK4 led to the question if the TCR 
signalling in Gadd45β-deficient thymocytes is impaired (Takekawa and Saito 1998). 
Moreover, if the interaction is impaired, whether this is related to the defects in apoptosis and 
subsequently also to the negative selection process in the thymus. 
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2. Materials 
2.1 Materials 
2.1.1 Chemicals 
If not particularly mentioned otherwise, all chemicals were obtained either from Sigma Aldrich 
(Munich, Germany), Roth (Karlsruhe, Germany) or Merck (Darmstadt, Germany). The BMFZ 
(Düsseldorf, Germany) generated the peptides for the stimulation of the transgenic mice. The 
two peptides were: PCC (pigeon cytochrome c; aa 88-104; KAERADLIAYLKQATAK) and 
VSV8 (vesicular stomatitis virus nucleoprotein); aa 52-59; RGYVYQGL. 
 
2.2 Cell Culture materials and devices 
The cell culture Flasks, 10 cm dishes 35 mm, 6-well, 12-well, 48-well and 96-well plates were 
provided by NUNC/ Thermo Fisher Scientific (Rochester, USA). The 10 µl sterile pipette tips, 
as well as the 1.5 ml and 2 ml small reaction tubes, were obtained from Sarstedt 
(Nümbrecht, Germany). Sterile serological pipettes with volumes of 5 ml, 10 ml and 25 ml 
were supplied by Sterilin – Thermo Fisher Scientific. 15 ml and 50 ml reaction tubes were 
used from Greiner bio-one (Frickenhausen, Germany). Sterile 200 µl and 1 ml pipette tips 
were obtained from Starlab (Ahrensburg, Germany). 45 µm and 20 µm sterile syringe filters 
were provided by Becton, Dickinson (Heidelberg, Germany) and Millipore (Waltham, USA).  
Cultivation conditions of 37°C at 5% CO2 and 95% air humidity were maintained by a 
HERAcell 240i from Thermo Scientific. A 5810R centrifuge from Eppendorf (Hamburg, 
Germany) was used to settle down the cells, which were handled in a Sterile Guard III by 
The Baker Company (Sanford, USA). 
 
 47 
2.2.1 Eukaryotic cell culture media and supplements 
 
Reagent Lot Order-
No. 
Company 
RPMI 1640 1003068 41965 GIBCO- life technologies (Grand 
Island, USA) 
DMEM 1149983 41965-
039 
GIBCO- life technologies 
Fetal Calf 
Serum (FCS) 
A10108-
2367 
A15-101 PAA (Pasching, Austria) 
Sodium-Pyruvate 
100 mM 
749750 11360 GIBCO- life technologies 
Non-essential 
amino acids 
930229 11140 GIBCO- life technologies 
Penicillin/ Streptomycin 5 
mg/ml 
918582 15070 GIBCO- life technologies 
β-Mercaptoethanol 
50 mM 
806672 31350 GIBCO- life technologies 
L-Glutamine 200 mM 831221 25030 GIBCO- life technologies 
MCSF BD 24232   Self purified 
 
2.2.2 Prokaryotic media 
 
Medium Components 
LB-medium 10 g/l Tryptone 
5 g/l Yeast extract 
10 g/l NaCl, pH 7.2 
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2.2.3 Medium for in vitro cultivation of primary T cells 
Primary, murine T cells were cultured in RPMI1640, supplemented with 10% FCS, 1 mM 
Sodium Pyruvate, 1x non-essential amino acids, 50 mg/ml Penicillin/ Streptomycin and 
50 µM β-Mercaptoethanol. 
 
2.2.4 Medium for in vitro cultivation of mouse embryonic fibroblasts (MEFs) 
If not suggested otherwise, mouse embryonic fibroblasts were cultivated in DMEM, 
complemented with 10% FCS and 50 mg/ml Penicillin/ Streptomycin. 
 
2.2.5 Medium for in vitro cultivation of bone marrow derived macrophages (BMDMs) 
Murine bone marrow derived macrophages were cultivated in DMEM, added with 10% FCS, 
2 mM Glutamine, 50 µM β-Mercaptoethanol, 50 mg/ml Penicillin/ Streptomycin and 5% 
MCSF BD 24232. 
 
2.2.6 Chemicals used for T cell stimulation 
 
Reagent Lot Order-No. Company 
Phorbol12-Myristate 
13-Acetate (PMA) 
16561-29-8 P8139 Sigma Aldrich 
Ionomycin (Iono) 56092-82-1 I-0634 Sigma Aldrich 
Dexamethasone  D4902-100mg Sigma Aldrich 
 
2.2.7 Antibodies used in cell culture 
 
Antibody Lot Clone Order-No. Company 
Anti-Murine CD3  145-2C11  Self purified 
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Anti-Murine CD28  E18  Self purified 
Anti-Murine CD95  Jo2 554254 Becton, 
Dickinson 
 
2.3.1 Eukaryotic cell lines 
Cell line Origin 
HEK 293T Human embryonic kidney 
MEF Mouse embryonic fibroblasts 
NIH/3T3 Mouse embryonic fibroblasts 
 
2.3.2 Eukaryotic primary cells 
Cells Origin 
Primary thymocytes Mouse thymus 
Bone marrow derived macrophages Mouse bone marrow 
CD4+, CD8+ T cells Mouse spleen, peripheral and mesenchymal 
lymph nodes 
 
2.4 Bacterial strains 
E. coli strain Genotype Application Reference 
source 
Top10 F– mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 ΔlacX74 
recA1araD139 Δ(ara leu) 7697 galU 
galK rpsL (StrR) endA1 nupG 
Amplification 
of plasmid 
DNA 
Invitrogen 
(Karlsruhe, 
Germany) 
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BL21 (DE3) 
gold 
E. coli B F– ompT hsdS (rB– mB–) dcm+ 
Tetr gal (DE3) endA Hte 
Expression of 
fusion protein 
Stratagene 
(Heidelberg, 
Germany) 
 
2.5 Mouse strains 
If not mentioned otherwise, in vivo experiments were performed with wild type mice of the 
C57BL/6 strain. The transgenic strains were: N15 TCR transgenic rag2-/- (Ghendler et al. 
1998), later referred as N15. The 5CC7 TCR transgenic rag2-/- on a C57BL/10 genetic 
background (Seder et al. 1992), later referred as 5CC7. The Gadd45β-/- mice on a C57BL/6 
genetic background (M. Gupta et al. 2005). The pCAG-GFP-LC3 transgenic mouse 
(Mizushima et al. 2004), later referred as GFP-LC3Tg/Tg. All mice were bred under specific 
pathogen free (SPF) conditions in the animal facility of the Helmholtz-Centre for Infection 
Research. If not specifically told otherwise, all experiments were done with littermate 
controls. 
 
2.6 Materials and reagents for flow cytometry 
2.6.1 Devices 
Samples that were pre-labelled were analysed on a FACS Canto, LSR II and a Fortessa by 
Becton, Dickinson. For cell purification, the samples were sorted either on a FACS Aria II by 
Becton, Dickinson or on a Moflo by Beckman Coulter (Indianapolis, USA). 
 
2.6.2 Fluorescent dyes 
 
Reagent Excitation Emission Oder-No. Company 
7-Aminoactinomycin D 546 nm 647 nm A 9400 Sigma-Aldrich 
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APC Annexin V 650 nm 660 nm 550475 Becton, Dickinson 
PE Annexin V 496 nm 578 nm 559763 Becton, Dickinson 
FITC Annexin V 495 nm 521 nm 556419 Becton, Dickinson 
LIFE/DEAD® Fixable 
Blue Cell Stain  
305 nm 450 nm L23105 Invitrogen 
Lysotracker-Red DND-
99 
577 nm 590 nm L7528 Invitrogen 
 
2.6.3. Fluorochrome-labelled antibodies 
 
Reactivity Dye Species Notation Order-
No. 
Company 
CD4 Pacific 
Blue 
Rat 
IgG2a, κ 
L3T4 100531 BioLegend 
CD4 APC Rat 
IgG2a, κ 
L3T4 100516 BioLegend 
CD4 PE Rat 
IgG2a, κ 
L3T4 553048 Becton, Dickinson 
CD5 PE Rat 
IgG2a, κ 
53-7.3 12-0051 eBioscience 
CD8a PerCP-
eFluor 
710 
Rat 
IgG2a, κ 
53-6.7 46-0081 eBioscience 
CD8a Horizon 
V500 
Rat 
IgG2a, κ 
53-6.7 560776 Becton, Dickinson 
CD19 PerCP-
Cy5.5 
Rat 
IgG2a, κ 
1D3 45-0193 eBioscience 
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CD24 FITC Rat 
IgG2b, κ 
M1/69 553261 Becton, Dickinson 
CD25 APC Rat 
IgG1, λ 
PC61.5 17-0251 eBioscience 
CD25 PE Rat 
IgG1, λ 
PC61.5 553866 Becton, Dickinson 
CD62L PE     
CD69 PE-Cy7 Hamster 
IgG 
H1.2F3 25-0691 eBioscience 
H57 APC IgG2, λ1 H57-597 561080 Becton, Dickinson 
Vβ  TCR Screening 
Panel (Vβ  2, 3, 4, 
5.1/5.2, 6, 7, 8.1/8.2, 
8.3, 9, 10b, 11, 12, 13, 
14, 17a) 
FITC   557004 Becton, Dickinson 
Foxp3 PE Mouse 
IgG1 
3G3 130-
093-014 
Miltenyi Biotech 
(Mönchengladbach, 
Germany) 
Foxp3 APC Mouse 
IgG1 
3G3 130-
093-013 
Miltenyi Biotech 
F4/80 PE Rat 
IgG2a, κ 
6F12 552958 Becton, Dickinson 
 
2.7 Materials and Reagents used for immunoblot 
PVDF membrane and photosensitive Hyperfilms were supplied by GE Healthcare 
(Buckinghamshire, UK). Tetra cell and criterion blotter for SDS-Page and protein transfer 
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were obtained from Bio-Rad Laboratories (Hercules, USA). ECL western blotting substrate 
was either supplied by Pierce/ Thermo Fisher or bought from Amersham/ GE Healthcare. 
2.7.1 Primary antibodies 
 
Antibody Reactivity Isotype Species Clone/ 
Notation 
Company 
Anti-
ATG12 
Human, 
Mouse, Rat 
(H, M, R) 
IgG Rabbit EAW48955 ProSci (Poway, USA) 
Anti-
ATG16L1 
H, M, R IgG Rabbit D6D5 Cell Signalling (Boston, 
USA) 
Anti-ATG5 H, M, R IgG Rabbit D1G9 Cell Signalling 
Anti-BIM H, M IgG2a, κ Rat 3C5 Alexis Biochemicals 
(New York, USA) 
Anti-c-MYC All IgG Rabbit 71D10 Cell Signalling 
Anti-FLAG H, M IgG1 Mouse F 1804 Sigma-Aldrich 
Anti-
Gadd45β  
M IgG Rabbit  Self Purified 
Anti-GST M IgG Goat 17-4577-01 Amersham Biosciences 
Anti-HA H, M IgG2b Mouse 12CA5 Roche Applied Science 
Anti-LC3B 
XP 
H, M IgG Rabbit D11 Cell Signalling 
Anti-
LC3A/B 
H, M IgG Rabbit 4108 Cell Signalling 
Anti-
MEKK4 
H, M, R IgG2b Mouse 6C6 Sigma-Aldrich 
Anti-Nur77 M IgG1 Mouse 12.14 Becton, Dickinson 
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Anti-p38 H, M IgG Rabbit 9212 Cell Signalling 
Anti-p38 
(P) 
H, M IgG Rabbit 9211 Cell Signalling 
Anti-
Tubulin 
H, M IgG1 Mouse DM1A Sigma-Aldrich 
Anti-V5 H, M IgG2a Mouse R960-25 Invitrogen 
Anti-β-
Actin 
H, M IgG2a Mouse AC-74 Sigma-Aldrich 
 
2.7.2 Horseradish peroxidase-conjugated secondary antibodies 
 
Reactivity Species Clone/ Notation Company 
Mouse IgG1 Goat  Southern Biotechnology 
(Birmingham, USA) 
Mouse IgG2a Goat  Southern Biotechnology 
Mouse IgG2b Goat  Southern Biotechnology 
Mouse IgG3 Goat  Southern Biotechnology 
Mouse IgG Goat  Dianova (Hamburg, Germany) 
Rabbit IgG Goat  Southern Biotechnology 
Rabbit IgG Goat  Dianova 
Rabbit IgL Mouse IgG1, κ  Jackson ImmunoResearch  
(Bar Harbor, USA) 
 
2.8 Polymerase chain reaction (PCR) 
All oligonucleotides were obtained from Eurofins MWG Operon (Ebersberg, Germany), 
HPLC- purified and lyophilised. All PCR were performed on a PeqStar cycler provided by 
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PeqLab (Erlangen, Germany). The quantitative real-time PCR was done on a LightCycler 
480 by Roche Applied Science (Basel, Switzerland). 
 
2.8.1 Oligonucleotides for PCR 
 
Name Application Sequence 5’3’ 
Gadd45β  fwd RT-PCR CAC CCT GAT CCA GTC GTT CT 
Gadd45β  rev RT-PCR TTG CCT CTG CTC TCT TCA CA 
Nur77 fwd RT-PCR TTC ATC CTC CGC CTG GCA TAC C 
Nur77 rev RT-PCR GTC CGA AGC TCA GGC AGT TTG C 
β-Actin fwd RT-PCR TGT TAC CAA CTG GGA CGA CA 
β-Actin rev RT-PCR TCT CAG CTG TGG TGG TGA AG 
FasL fwd RT-PCR CGG TGG TAT TTT TCA TGG TTC TGG 
FasL rev RT-PCR CTT GTG GTT TAG GGG CTG GTT GTT 
Bim fwd RT-PCR CTG AGT GTG ACA GAG AAG GTG G 
Bim rev RT-PCR GTG GTC TTC AGC CTC GCG GT 
Gadd45β  qRT fwd qRT-PCR CTG CCT CCT GGT CAC GAA 
Gadd45β  qRT rev qRT-PCR TTG CCT CTG CTC TCT TCA CA 
 
2.9 Materials and Reagents for confocal laser scanning microscopy 
The fluorescent microscopic pictures were either taken with a Leica TCS SP5 II (Wetzlar, 
Germany) confocal laser scanning microscope (CLSM) or with a Nikon Eclipse Ti 
(Düsseldorf, Germany) microscope, additionally equipped with the spinning disc module 
UltraVIEW VoX by PerkinElmer (Waltham, USA). 
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2.9.1 Primary antibodies 
 
Antibody Reactivity Isotype Species Clone/ Notation Company 
Anti-c-MYC All IgG Rabbit 71D10 Cell Signalling 
Anti-MEKK4 H, M, R IgG2b Mouse 6C6 Sigma-Aldrich 
Anti-V5 H, M IgG2a Mouse R960-25 Invitrogen 
Anti-p38 (P) H, M IgG Rabbit 9211 Cell Signalling 
Anti-HA H, M IgG2b Mouse 12CA5 Roche Applied Science 
 
2.9.2 Fluorochrome-labeled secondary antibodies 
 
Antigen Reactivity Species Dye Application Company 
IgG Mouse Goat AlexaFluor 
405, 488, 594, 
633 
Immunofluorescence 
(IF) 
Molecular 
Probes/ life 
technologies 
IgG1 Mouse Goat AlexaFluor 
488, 594 
IF Molecular 
Probes/ life 
technologies 
IgG2a Mouse Goat AlexaFluor 
488, 594 
IF Molecular 
Probes/ life 
technologies 
IgG2b Mouse Goat AlexaFluor 
488, 594 
IF Molecular 
Probes/ life 
technologies 
IgG Rabbit Goat AlexaFluor 
405, 488, 594, 
633 
IF Molecular 
Probes/ life 
technologies 
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2.10 Frequently used buffers 
Group Buffer Components 
Cellular Buffers PBS 138 mM NaCl 
 8.1 mM Na2HPO4 
 2.7 mM KCl 
 1.5 mM K2HPO4, pH 7.4 
TBS 50 mM Tris 
 150 mM NaCl, pH 7.4 
FACS Buffer 2% w/v BSA 
 in PBS 
MACS Buffer 2% w/v BSA 
 in PBS 
Annexin V Binding Buffer 10 mM Hepes/ NaOH pH 7.4 
 140 mM NaCl 
 2.5 mM CaCl2 
CLSM Blocking Buffer 4% w/v BSA 
 0.05% w/v Saponin 
 in PBS 
Lysis Buffers TPNE Final concentration 300 mM NaCl 
 1% v/v Triton X-100 
 2 mM EDTA 
 in PBS 
 pH 7.4 
DISC 30 mM Tris/ HCL pH 7.4 
 150 mM NaCl 
 10% v/v Glycerol 
 1% w/v Triton X-100 
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 2 mM EDTA 
 10 mM NaF 
RIPA 50 mM Tris pH 7.4 
 1% NP40 
 0.5% Sodium Deoxycholat 
 0.1% SDS 
 150 mM NaCl 
 1 mM EDTA 
 1 mM NaF 
   
Immunoblot Buffers 5x Laemmli 
(Laemmli 1970) 
50 mM Tris, pH 8.8 
 10% w/v SDS 
 25% v/v β-Mercaptoethanol 
 50% v/v Glycerol 
 0.25 mg/ml Bromphenolblue 
Running Buffer 25 mM Tris, pH 8.0 
 192 mM Glycerol 
 1% v/v SDS 
Transfer Buffer 25 mM Tris, pH 8.0 
 192 mM Glycerol 
 20% v/v Methanol 
Block Buffer 5% w/v non-fat dry milk 
 0.2% v/v Tween-20 
 in TBS 
Wash Buffer 0.05% v/v Tween-20 
 in TBS 
100x protease inhibitors 100 µg/ml Apotinin 
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 100 µg/ml Leupeptin 
 100 µg/ml Chymostatin 
 100 µg/ml Pepstatin A 
3. Experimental Procedures 
3.1 Molecular Methods 
3.1.1 Isolation of eukaryotic RNA 
The RNA of eukaryotic cells was isolated from purified mammalian cells using a RNeasy Kit 
from Qiagen (Hilden, Germany). The cell lysis was performed with the QIAshredder columns, 
also from Qiagen. Both procedures were done according to manual. 
 
3.1.2 Isolation of prokaryotic plasmid DNA 
The preparation of plasmid DNA out of E. Coli was done with a NucleoBond® Xtra Maxi EF 
Kit, provided by Macherey-Nagel (Düren, Germany). The experimental procedure was 
performed according to the manufacturers manual. 
 
3.1.3 Photometric determination of DNA/RNA concentration 
DNA/RNA concentrations were determined by a Nanodrop 2000c (Thermo Scientific). 
Calculations were done according to the Lambert-Beer function: 
 
E = c*ε*d <=> c = ε*d*E-1 
 
E = extinction 
c = concentration [mol/l] 
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ε = coefficient of extinction [M-1*cm-1] 
d = density of the cuvette [cm] 
 
3.1.4 Reverse Transcription 
Purified RNA was transcribed into copyDNA (cDNA) for subsequent PCR analysis with the 
help of the RevertAid™ Premium First Strand cDNA Synthesis Kit (Thermo Scientific). 
Poly(A) tailed mRNA was specifically transcribed using Oligo(dT)18 primers. 
 
3.1.5 Polymerase chain reaction 
DNA fragments were amplified by PCR, using 2x KAPA ReadyMix (Peqlab). This was done 
either for subsequent analysis of cDNA (as described in 3.1.4) or genotyping. No proof-
reading capability is required for both applications. For any other procedure, Phusion® 
High-Fidelity DNA Polymerase (New England Biolabs, Ipswich, USA) was used.  
 
PCR components were mixed according to the following pattern: 
 
Component Amount 
cDNA Template 1 µl (~50-100 ng) 
2x ready-to-use mix 12.5 µl 
Forward Primer 100 pM 1 µl 
Reverse Primer 100 pM 1 µl 
Dest H2O Up to total amount of 25 µl 
 
The PCRs were incubated in a PeqSTAR thermocycler according to the template program 
shown below. The hybridisation temperature was chosen 3°C under the TM of the primer 
combination. 
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Time Temperature Function No. of Cyles 
5 min 94°C Initial denaturation 1 
30 sec 94°C Denaturation  
25-34 cycles 30 sec 60°C (+/-x°C) Hybridization 
30 sec 72°C Elongation 
10 min 72°C Terminal elongation 1 
 
3.1.6 Analytic agarose gel electrophoresis 
DNA fragments were separated according to their length in a 1-2% agarose gel in an electric 
field of 150mA. The horizontal gel-electrophoresis system perfectBlue M (PeqLab) was used. 
The run was done in TAE buffer (40 mM Tris pH 8.0, 20 mM acetic acid, 1 mM EDTA) with 
0.5 µg/ml ethidium bromide. The intercalated ethidium bromide was visualised by UV-light 
(λ=254 nm). Sizes were checked against a low range 1-500 bp or 1 kB DNA ladder from 
PeqLab. 
 
3.1.7 Quantitative real-time polymerase chain reaction 
The quantitative real-time polymerase (qPCR) was used to both detect and quantify specific 
sequences in a DNA sample. In the context of this work it was used following reverse 
transcription. The non-specific fluorescent dye SYBR Green (Roche), which intercalates into 
the double-stranded DNA, is measured after each cycle, thus allowing the DNA 
concentrations to be quantified against a known standard. 
Given the fact that SYBR green detects every double-stranded DNA, a subsequent melting 
point analysis was done to discriminate between the correct product of the qPCR and 
artefacts, such as primer-dimers. As the disassociation of short, double-stranded DNA is 
faster than the one of longer fragments, this is an easy way to assure the correct 
amplification product. 
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3.2 Biochemical Methods 
3.2.1 Cell Lysis 
For whole cell extracts 1x106 to 5x106 cell lysates were prepared in 50 µl of adequate lysis 
buffer, depending on the subsequent analysis (see 2.10). All buffers were freshly 
complemented with 1 mM PMSF and 1 µg/ml each of leupeptin, aprotinin, chymostatin and 
pepstatin A. If subsequent analysis of the phosphorylation state of a protein was important, 1 
tablet of PhosSTOP Phosphatase Inhibitor Cocktail (Roche) was added. 
subsequently, the cell extracts were kept for 20 min on ice and subsequently centrifuged for 
15 min at 20,000 g. The supernatant was transferred into a pre-chilled tube and used for 
futher experiments. 
 
3.2.2 Determination of total protein concentration 
The total protein amount of lysates as generated in 3.2.1 was determined by bichinchoninic 
acid (BCA) protein assay reagent provided by Pierce/ Thermo Fisher according to the 
manufacturer’s protocol. Here, the total protein concentration is detected by a colour change 
of the sample solution from green to purple, which correlates in linear way (P. K. Smith et al. 
1985). This colour change was measured at a wavelength of 562 nm with a TECAN infinite 
200M plate reader (Männedorf, Switzerland). 
 
3.2.3 Immunoprecipitation 
Immunoprecipitation was used to achieve a well-directed enrichment of a particular protein 
out of a whole-cell lysat (see 3.2.1) or to detect a particular protein-protein interaction. To this 
end, either Protein A Sepharose CL-4B (Sigma-Aldrich) in a 50% slurry or Protein G 
Dynabeads® Magnetic Beads (Invitrogen) were incubated for 4 h at 4°C under constant 
rotation with the designated antibody. Depending on the antibody, between 2-5 µg were used 
for each sample of beads (20 µl for Dynabeads®, 35 µl for Protein A Sepharose).  
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Subsequently, the beads were washed three times to get rid of unbound antibody. 200 µl of 
whole lysate was added to the beads and filled up to 750 µl with the corresponding buffer. 
The samples were rotated either for 4 h or over night at 4°C and then unbound protein was 
washed away three times with 500 µl of the buffer. The beads were taken up in 20 µl 
Laemmli buffer (see 2.10), incubated for 5 min at 95°C and subsequently analysed by 
SDS-PAGE and immunoblot. 
 
3.2.4 SDS-PAGE 
20 µg of total protein lysate was mixed with 5x Laemmli buffer (see 2.10) to a final 
concentration of 1x and heated for 5 min at 95°C. Then, the sample was loaded and 
separated in a polyacrylamide gel from 8-20%, according to the size of the protein of interest. 
To this end, a Biorad tetra cell was used. The gel was run at 33 mA per gel and 80 V until the 
separation was completed. 
 
3.2.5 Immunoblot 
The proteins that were separated in the gel were subsequently transferred to a 
Polyvinylidene Fluoride (PVDF) membrane (GE Healthcare), using a Biorad criterion blotter 
in 1x transfer buffer (see 2.10) at 500 mA at 80 V for 90 min. Then, the membrane was 
incubated in with blocking buffer (see 2.10) for at least 1 hour at room temperature under 
constant gentle shaking and afterwards placed in blocking buffer containing primary antibody 
diluted to the suppliers instructions and incubated over night at 4°C in an overhead mixer. 
After washing three times with immunoblot washing buffer (see 2.10), the membranes were 
subjected to the secondary antibody, diluted in 1x TBS for at least 1 hour at room 
temperature. After subsequent washing for three times with washing buffer the proteins were 
detected by SuperSignal West Dura substrate from Pierce/ Thermo Fisher Scientific or ECL 
Select™ from Amersham/ GE Healthcare. 
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3.2.6 Coomassie Blue staining 
 
Proteins that were separated via SDS-PAGE were subsequently stained and fixed with the 
PageBlue Protein Staining Solution from Pierce/ Thermo Fisher Scientific. The solution 
contains the triphenylmethane dye Coomassie Brilliant Blue G250. After 30 min of staining, 
the gel was decoloured by rinsing the gel 2-3 times with millipore water under gentle 
shacking until the background was completely clear of the dye. 
 
3.2.7 P33 detection in SDS-PAGE 
MEFs were cultivated for 2 days in cell culture flasks and then washed twice with TBS. 
Subsequently, they were cultivated for 20-30 min in DMEM w/o PO43-(Invitrogen). Following 
this starvation period, 2 mCi P33 (Hartmann Analytic, Braunschweig, Germany) were added 
to the medium and the cells were incubated for another 4 h. Then, the medium was 
discarded and the uptake was stopped with ice-cold PBS supplemented with NaF 10 mM, 
NaVO4 0.4 mM, EDTA 0.4 mM, Na4P2O7 10mM. The cells were lysed and subjected to 
immunoprecipitation (see 3.2.3) and subsequent SDS-PAGE in a NuPAGE® 4-20% SDS gel 
(Invitrogen). The gel was fixed (MeOH 20% v/v, acetic acid glacial 10% v/v) for 30 min and 
subsequently treated for 30 min with NAMP100 Amplify Solution (Amersham, 
GE Healthcare). Subsequently, the gel was dried and exposed to x-ray films where the 
irradiation blackened the film. 
 
3.2.8 Enzyme-Linked Immunosorbent Assay 
An enzyme-linked immunosorbent assay (ELISA) was done to verify and quantify the 
specificity of a given antibody against its respective antigen. To this end, the antigen (100 µl 
in a 2 µg/ml solution in PBS) was bound overnight at 4°C to a 96-well flat-bottom plate 
(NUNC). Subsequently, unbound protein was washed away 3x with TBS-Tween 
(immunoblotblot washing buffer, see 2.10). The coated plate was incubated for 2 hours with 
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a blocking solution (2% (w/v) BSA in TBS-T) under gentle pivoting. By this means, the whole 
surface of the plate was saturated to prevent unspecific binding of the antibody later on. 
The plate was then washed three times with the washing buffer and subsequently each well 
was covered with 100 µl of the diluted serum for 1 hour. Afterwards, the plate was again 
washed three times and then incubated for 45 min with a secondary, horseradish peroxidase 
coupled antibody against the respective first antibody. The antibody was diluted in a range 
from 1:2,000 to 1:5,000. Followed by three washing steps, 50 µl for each well of developing 
fluid (9 ml 0.11 M Na2HPO4, 1 ml 0.5 M citric acid, 10 mg OPTG, 10 µl 33% H2O2) was 
added. The colour change could usually be observed within minutes and then detected with 
a plate reader at a wavelength of λ=450 nm. 
 
3.3 Cell biological methods 
3.3.1 Transient transfection 
Depending on the type of cell and the plasmid used, either jetPEI® by Polyplus-transfection 
(Illkirch Cedex, France), or Lipofectamine™ 2000 by Invitrogen were applied to transiently 
transfect the cells according to the manufacturers manual. 
 
3.3.2 Production of Lentiviruses 
Lentiviral transduction is an efficient way to incooperate genetic material stably into a given 
cell line. In order to produce the virus particles, HEK293T cells were seeded in 10 cm dishes. 
Three different preparations were made (each with 10 µg DNA per dish): The viral transfer 
vector including the target gene, the envelope plasmid and a third one encoding for viral 
structure proteins and the reverse transcriptase. 24 h 48 h post transfection the medium was 
exchanged and the viral containing medium was filtrated (0.45 µm, PVDF-membrane) and 
subsequently concentrated via ultracentrifugation (100000 g, 1 h, 4°C). The virus pellet was 
resuspendet thoroughly in PBS and stored at -80°C. 
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3.3.3 Transduction of cells with viral particles 
For each approach of target cells, one batch of viral particles was used. Together with the 
cells, the virus particles were spun down for 1 h at 2000 rpm at 25°C. In order to enhance the 
effectiveness of the transduction, 8 µg/ml polybren were added. Subsequently, the cells were 
cultivated for 16 h under standard cell culture conditions. Then, the medium was changed 
and the cells were analysed for positive transduction. 
 
3.4 Production and filtration of recombinant proteins 
3.4.1 Expression of recombinant proteins 
For the expression and subsequent filtration of the recombinant proteins, 500 ml of antibiotic 
containing LB medium (see 2.2.2) was inoculated with the respective Bl-21(DE3) strain of 
E. Coli and incubated at over night at 37°C at 220 rpm. The culture was then thinned with 
fresh LB medium to an optical density OD600 of 0.5 and incubated for another 30 min. 
Subsequently, the overexpression was started by addition of IPTG (Berkshire, UK). After 
induction, the bacteria were centrifuged for 10 min at 6000 rpm in a 5810R centrifuge from 
Eppendorf, the supernatant was then discarded and the pellet resuspended in 40 ml PBS. 
The bacteria were solubilised by ultrasonic (1 min, 70% power, Sonoplus Bandelin, Berlin, 
Germany) and subsequently centrifuged for 1 hour at 20000 rpm at 4°C. The supernatant 
was separated and according to the protein in question either the soluble or the unsoluble 
fraction was filtrated. 
 
3.4.2 Dialysis 
Dialysis allows to exchange the buffer of a given sample against another one, e.g. PBS. Prior 
to the procedure, the tube itself has to be cleared of heavy metal ions, which are a 
by-product of the manufacturing process. To this end, the tubes are heated for 2 hours at 
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60°C in a 1M NaCO3 and 20 mM EDTA buffer solution, followed by a thorough flushing of the 
tube. The ratio of dialysed sample to dialysis buffer (PBS) must be 1:100, the process was 
done over night at 4°C under very gentle stirring. 
 
3.4.3 Purification of polyclonal antibodies 
In order to obtain a working anti-Gadd45β antibody, rabbits were immunised against 
full-length protein of Gadd4β. The sera were extracted after 120 days of immunisation and 
subjected to an ELISA analysis to verify specificity against the antigen. The sera were then 
diluted 1:10 with PBS and enriched with the help of a 5 ml protein G column, provided by 
Pierce/ Thermo Fisher Scientific in a Fast Protein Liquid Chromatography (FPLC) (UPC-900, 
GE-Healthcare). After FPLC purification, the samples were dialysed, the protein 
concentration was measured and the purity was confirmed with the help of a SDS-PAGE with 
subsequent coomassie staining. 
 
3.5 Confocal laser scanning microscopy (CLSM) 
3.5.1 Preparation of fixed samples 
Adherent cells (mouse embryonic fibroblasts, MEFs) were seeded on a coverslip in a 12-well 
plate (NUNC) and then cultured over night for adherence. Depending on the experimental 
design, the cells were then subjected to the treatment in question. Subsequently, the cells 
were washed once with PBS and then fixed for 15-20 min with a freshly prepared 4% 
paraformaldehyde solution, diluted in PBS. After 3 washing steps with PBS for 5 min at room 
temperature, the cells were blocked and made permeable for 30 min with the CLSM blocking 
buffer (see 2.10). Afterwards, the cells were incubated over night, if necessary, with the first 
antibody at 4°C in CLSM blocking buffer. The manufacturer supplied the proper dilutions of 
the antibodies. After again 3 times washing with PBS, the corresponding, 
fluorochrome-labelled secondary antibodies (see 2.9.2) were applied for 45-120 min in CLSM 
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blocking buffer. Subsequently, the cells were washed again and if required stained with 
DAPI. The cover slip was then mounted with the help of mounting medium (Dako, Glostrup, 
Denmark) on a microscope slide and was kept at 4°C until usage. All steps from the instant 
of permeabilisation were performed under the exclusion of light. 
 
3.5.2. In vivo imaging of primary T cells 
LC3-GFP+ T cells out of the thymus, spleen and peripheral lymph nodes were subjected to 
CLSM microscopy in an 8-well cell culture chamber (Sarstedt, Germany) pre-coated with 
Poly-L-Lysine (Sigma Aldrich) and kept at 37°C in a 5% CO2 and 95% air humidity 
atmosphere during the whole experiment. The cells were stimulated with 20 ng/ml PMA and 
1 µM Ionomycin and GFP-induction was observed in a time-dependent manner with a 
confocal microscope. 
 
3.6 Cellular and mouse surgical methods 
3.6.1 Isolation of lymphoid organs from mice 
For the analysis of primary T cells, the thymus, spleen, mesenteric and peripheral lymph 
nodes were surgically removed from mice sacrificed either by cervical dislocation or by the 
exposition to high concentrations of CO2. The organs were milled through a 45 µm filter and 
were suspended in 6.5 ml PBS. The cells were kept on ice at all times. 
 
3.6.2 Flow cytometric analysis 
2*106 cells, isolated as described in 3.5.1, were washed twice with 1 ml of FACS buffer (see 
2.10) and resuspended in 250 µl of the same. Then, the cells were stained with the proper 
antibodies (see 2.6.3) with the dilutions specified by the manufacturer or with a 
self-determined concentration through at 4°C for 15-30 min. Subsequently, the cells were 
washed twice with 1 ml FACS buffer and then analysed in a LSR II Special Order System by 
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Becton, Dickinson. Intracellular staining of Foxp3 was done according to the manual either 
with a Kit from eBioscience or from Miltenyi Biotech. 
 
3.6.3 Cell isolation via flow cytometry 
The cells were collected as described in 3.5.1 and stained as described in 3.5.2 with the 
exception that PBS replaced the FACS buffer. Subsequently, they were sorted in a FACS 
Aria II (Becton, Dickinson) or a Moflo (Beckmann and Coulter). The cells were collected in a 
tube already containing the proper medium. The cells were sorted with the help of Dr. Lothar 
Gröbe from the sorting facility of the Helmholtz-Centre for Infections Research. 
 
3.7 Quantification and Statistical analysis 
3.7.1 Quantification of confocal laser scanning microscopy images 
All confocal laser scanning microscopy images were quantified with the Volocity 3D Image 
Analysis Software by PerkinElmer. At least 50 cells were analysed for each quantification. 
Depending on the reporter construct that was used, either autophagosomes or 
autophagosomes and autophagolysosomes were counted. The software discriminated 
genuine signal against unspecific background via reconciliation of the intensity. To this end, 
all pictures of the same experiment were recorded with the same laser intensities. In the 
case of the Leica TCS SP5 II the settings of the photomultipliers were left untouched in the 
course of one experiment, with the Nikon Eclipse Ti equipped with the UltraVIEW VoX 
spinning disc module the exposure time of the CCD cameras staid the same. 
The software used the watershed algorithm (Beucher 1992) to separate two signals that 
were closely adjoined and was set to reject every signal smaller than 0.15 µm2. As a general 
guideline, it was programmed to look for round objects the size of 1.5 µm2 to 3 µm2. 
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3.7.2 Statistical analysis 
All statistics were evaluated with the help of the statistical software Graph Pad Prism from 
Graph-Pad-Software Inc. (La Jolla, USA). Statistical significance was calculated by the 
two-tailed Mann-Whitney U test. Standard deviation (s.d.) and standard error of the mean 
(s.e.m.) were represented as error bars.  
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4. Results 
4.1 The Role of Gadd45β in autophagy 
4.1.1 Gadd45β  together with MEKK4 overexpression results in an increased number 
of GFP-LC3 positive intracellular structures 
Gadd45β has been reported to interact with the mitogen-activated protein kinase (MAP3K) 
MEKK4 to activate the MAPK p38 (Takekawa and Saito 1998). Although this finding was 
limited to classical p38 activation and apoptosis, it could be shown that the activation of p38 
by Gadd45β/MEKK4 has an impact on autophagy by guiding the phosphorylated p38 to 
autophagosomes in the cytoplasm (Keil 2008). The MAPK p38α could also be linked to 
autophagy through the interaction with Atg9 (Webber and Tooze 2010). Additionally, p38 
could be identified to positively regulate oridonin-induced autophagy, be involved in glial 
fibrillary acidic protein-dependent autophagy and in Atg9-dependent, starvation induced 
autophagy (Tang et al. 2008; Cui et al. 2007; Webber and Tooze 2010). Along these lines, 
the transfection of Gadd45β either alone or together with MEKK4 into NIH/3T3 cells stably 
expressing GFP-LC3 could significantly raise the numbers of intracellular GFP-LC3 spots 
24 h post transfection (Fig. 10a). In order to quantify this finding, 50 cells of each transfection 
(Gadd45β alone, MEKK4 alone, Gadd45β and MEKK4 together and an empty vector control) 
were analysed by confocal microscopy and counted with the help of the Volocity imaging 
software.  
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Figure 10: The influence of Gadd45β /MEKK4 overexpression on autophagosome formation in 
NIH/3T3 cells. 
(a) NIH/3T3 cells stably expressing GFP-LC3 were transfected either with an empty vector, Gadd45β, 
MEKK4 or both of the latter. 24 h later confocal microscopy images were taken and the number of 
GFP-LC3 positive autophagosomes for each cell was counted in 50 cells per condition. Bars represent 
10 µm. (b) The number of autophagosomes per cell in a statistic analysis. Significances were 
calculated by two-tailed Mann-Whitney tests (n=50, mean ± s.d., * P=0.0149, ** P=0.001, *** 
P<0.0001).  
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As a result it could be shown, that the co-expression of Gadd45β with MEKK4 significantly 
raised the amount of intracellular GFP-LC3 positive structures, i.e. autophagosomes. The 
overexpression of Gadd45β alone did also induce an increase in autophagosomal structures, 
but not to the same extend as both proteins did. Interestingly, MEKK4 transfection alone did 
not significantly raise the intracellular autophagy level. In summary, it could be shown that 
not only activated, phosphorylated p38 was directed to autophagosomes, but that p38 also 
seems to exert a functional role at these structures (Keil 2008). 
4.1.2 The Gadd45β /MEKK4 pathway blocks starvation-induced autophagy 
As could be shown in 4.1.1, Gadd45β together with MEKK4 transfection into NIH/3T3 cells 
stably expressing GFP-LC3 highly increased the number of GFP+ cytosolic structures in the 
cell. However, in order to get a more detailed view of how p38 through the interplay of 
Gadd45β and MEKK4 influences autophagy, this method is insufficient. Thus, to quantify 
autophagy properly, it is important to differentiate between a higher amount of 
autophagosomes as a result of higher expression levels of autophagy-relevant proteins (in 
this case LC3) or because of a block in the autophagic flux. Both situations ultimately result 
in more GFP+ cytosolic structures, i.e. autophagosomes (Klionsky et al. 2008). To be able to 
discriminate between the two different reasons of increased autophagosomes in the 
cytoplasm, the cells were transfected with an RFP-GFP-LC3 reporter construct (Kimura et al. 
2007). 
The function of the green fluorescent protein is more prone to acidic lysosomal degradation 
than the one of the red fluorescent protein, thus the emission of the green light is abbreviated 
earlier than the emission of the red light. A not-yet fused autophagosome would thereby be a 
RFP+GFP+ double positive structure in the cytoplasm, as opposed to a single positive RFP+ 
spot that would mark an autophagosome already fused with a lysosome, an autolysosome. 
Thus, this method allows for monitoring of the autophagic flux. 
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NIH/3T3 cell line stably expressing RFP-GFP-LC3 were transfected with V5-tagged 
Gadd45β, MEKK4-HA or both and were subjected 24 h post-transfection to 4 h of 
HBSS-induced starvation (Fig. 11a). 
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Figure 11: Gadd45β  inhibits starvation-induced autophagic flux. 
(a) NIH/3T3 cells stably expressing RFP-GFP-LC3 were transiently transfected with V5-tagged 
Gadd45β and HA-tagged MEKK4. 24 h post-transfection, the cells were fixed and stained either with 
anti-HA or anti-V5 antibody (AF633). Subsequently, samples were analysed by confocal microscopy. 
Representative images are shown. Bars, 10 µm. (b) Quantification of the experiment shown in (a). The 
number of autophagosomes (RFP+GFP+) and autolysosomes (RFP+GFP-) per cell was counted in 50 
cells per condition ± s.e.m. 
 
As observed with the GFP-LC3 reporter construct, the transfection of Gadd45β alone had a 
high effect on the rate of on-going autophagy. MEKK4 transfection alone did not alter the 
amount of either autophagosomes or autolysosomes, starved or under nutrient-sufficient 
conditions (Fig. 11b). Starvation had also no effect on the autophagic levels in Gadd45β 
transfected cells. Moreover, the co-transfection of Gadd45β and MEKK4 led to an increase in 
autophagosome numbers but not in autolysosomes. Again, starvation did not significantly 
alter the dynamics of the autophagic flux. Both experiments together show the influence of 
Gadd45β and MEKK4 on cellular macroautophagy. 
4.1.3 p38-deficiency leads to a highly increased amount of autophagosomes but only 
to a minor increase of autolysosomes 
(p)p38 colocalisation with autophagosomes could be identified via confocal microscopy and 
phosphorylated, thus activated, (p)p38 could be found in lysates cotransfected with Gadd45β 
and MEKK4 without further stimulation. To identify the role that p38 plays in the autophagy 
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pathway, the effect of a p38α gene knockout was determined by analysing confocal 
microscopy images of p38α-/- (Adams et al. 2000) and the corresponding wild type MEFs 
(Fig 12a). To quantify these numbers in a statistical adequate approach, pictures of 50 cells 
per condition were made by confocal microscopy and subsequently analysed with the help of 
imaging software. 
 
 
Figure 12: p38-deficiency severely decreases the amount of autophagosomes but not 
autolysosmes under starvation conditions. 
(a) p38+/+ and p38-/- MEFs were transfected with the RFP-GFP-LC3 reporter constructed. 24 h 
post-transfection the cells were starved for 4 h in HBSS or left untreated. Subsequently, the cells were 
fixed and analysed by confocal microscopy for GFP-RFP localisation. Bars represent 10 µm. (b) 
Statistical significances were calculated by two-tailed Mann-Whitney tests (n=50, mean ± s.d., * 
P=0.0142, *** P<0.0001, n.s. = not significant).  
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After quantitative analysis and statistic evaluation, the result showed that in p38 wildtype 
MEFs the number of autophagosomes (RFP+GFP+) as well as the number of autolysosomes 
(RFP+) decreased upon starvation, whereas in the p38-deficient situation the number of both 
stayed the same (Fig. 12b). Comparing the results of both genotypes amongst each other, 
the most striking differences were observed in the number of autophagosomes. Irrelevant of 
the nutrition conditions, both results showed a highly significant increase in autophagosome 
numbers (P<0.0001) in the p38-deficient MEFs. The statistical analysis was calculated using 
the two-tailed Mann-Whitney test (n=50, mean ± s.d.). Further downstream of the autophagic 
flux, the tendency still remained the same but only to a minor extent (P=0.0142 for starvation 
conditions, n.s. for non-starvation conditions). Taken together, these results indicate that 
p38-deficiency results in a severe deregulation of the autophagic flux, irrespective of an 
acutely stimulated situation or the basal autophagy levels in an unstimulated condition. 
 
4.1.4 Atg5 is a substrate of p38 
The previous results show the impact that Gadd45β and MEKK4 exert on cellular 
macroautophagy through p38. To qualify as a target of MAPKs, a protein has to have a 
specific conserved S/T-P motif (Shaul and Seger 2007), meaning that every serine or 
threonine which can be phosphorylated has to be followed by a proline. Through numerous 
studies in yeast, many of the important molecules and their homologues in mouse and men 
could already be identified (Levine and Deretic 2007). Of the most prominent autophagy 
related proteins, an alignment showed Atg5 to have two such potential phosphorylation sites, 
at T75 and T249 (Fig. 13a). Atg5 has previously been shown to have a critical role in 
macroautophagy (Kuma et al. 2004). Of those two potential phosphorylation sites, only the 
TP binding site at position 75 is conserved through all species from men to yeast, the TP 
binding site at location 249/250 is not conserved in Saccharomyces cerevisiae, Drosophila 
melanogaster and Rattus novegicus. Those three species also show the lowest overall 
homology of Atg5 as compared to mouse (Fig. 13b). Not surprisingly, Homo sapiens showed 
the highest homology to murine Atg5, 96.7% as opposed to Saccharomyces cerevisiae with 
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a homology of only 23.4%. Interestingly, Danio rerio, being a member of the class of the 
Actinoptygii, shows an Atg5 homology of 79.4% to mice as opposed to Rattus norvegicus 
with a homology of only 62.3%. Therefore, although being more closely related to the mouse 
in respect to the degree of kinship, the autophagic machinery is not as nearly related in the 
rat. 
 
Mus musculus
Homo sapiens
Bos taurus
Sus scrofa
Gallus gallus
Danio rerio
Rattus norvegicus
D. melanogaster
S. cerevisiae
M. musculus H. sapiens B. taurus S. scrofa G. gallus D. rerio R. norvegicus D. melanogaster S. cerevisiae
a
b
                     1        10        20        30        40        50        60
                     |        |         |         |         |         |         | 
      Mus musculus   MTDDKDVLRDVWFGRIPTCFTLYQDEI---TEREAEPYYLLLPR----VSYLTLVTDKVK
      Homo sapiens   MTDDKDVLRDVWFGRIPTCFTLYQDEI---TEREAEPYYLLLPR----VSYLTLVTDKVK
        Bos taurus   MTDDKDVLRDVWFGRIPTCFTLYQDEI---TEREAEPYYLLLPR----VSYLTLVTDKVK
        Sus scrofa   MTDDKDVLRDVWFGRIPTCFTLYQDEI---TEREAEPYYLLLPR----VSYLTLVTDKVK
     Gallus gallus   MTDDKDVLRDVWFGRIPTCFTLYQDEI---TEREAEPYYLLLPR----ISYLTLVTDKVK
       Danio rerio   MADDKDVLRDVWFGRIPACFTLSPDET---TEREAEPYYLLLPR----VSYLTLVTDKVK
 Rattus norvegicus   MTDDKDVLRDVWFGRIPTCFTLYQDEI---TEREAEPYYLLLPR----VSYLTLVTDKVK
   D. melanogaster   MAHDREVLRMIWEGQIGICFQADRDEI---VGIKPEPFYLMISR----LSYLPLVTDKVR
     S. cerevisiae   MNDIKQLL---WNGELNVLVSIDPSFLMKGSPREIAVLRIRVPRETYLVNYMPLIWNKI-
      Mus musculus   KHFQKVMRQEDVS-EIWFEYEGTPLKWHYPIGLLFDLL-ASSSALPWN-----------I
      Homo sapiens   KHFQKVMRQEDIS-EIWFEYEGTPLKWHYPIGLLFDLL-ASSSALPWN-----------I
        Bos taurus   KHFQKVMRQEDIS-EIWFEYEGTPLKWHYPIGLLFDLL-ASSSALPWN-----------I
        Sus scrofa   KHFQKVMRQEDIS-EIWFEYEGTPLKWHYPIGLLFDLL-ASISALPWN-----------I
     Gallus gallus   KHFQKVMRQEEVN-EIWFEYEGTPLKWHYPIGLLFDLH-ASNTALPWS-----------I
       Danio rerio   KHFLKVMKAEDVE-EMWFEHEGTPLKWHYPIGVLFDLH-ASNSALPWN-----------V
 Rattus norvegicus   KHFQKVMRQEDVS-EIWFEYEGTPLKWHYPIGLLFDLL-ASSSALPWN-----------I
   D. melanogaster   KYFSRYISAEHQDGAVWFDFNGTPLRLHYPIGVLYDLLHPEEDSTPWC-----------L
     S. cerevisiae   KSFLSFDPLTDSEKYFWFEHNKTPIPWNYPVGVLFDCLAGKSATFTTSFENQVKDVLTFL
      Mus musculus   TVHF---KSFPEKDLLHCPSKDAVEAHFMSCMKEAD-ALKHKSQVINEMQKKDHKQLWMG
      Homo sapiens   TVHF---KSFPEKDLLHCPSKDAIEAHFMSCMKEAD-ALKHKSQVINEMQKKDHKQLWMG
        Bos taurus   TVHF---KSFPEKDLLHCPSKDVIEAHFMSCVKEAD-ALKHKSQVINEMQKKDHKQLWMG
        Sus scrofa   TVHF---KSFPEKDLLHCPSKDVIEAHFMSCVKEAD-ALKHKSRVISDMQRKDHKQLWMG
     Gallus gallus   TVHF---KNFPEKDLLHCHSKDVIEAHFMACIKEAD-ALKHKSQVINEMQKKDHKQLWMG
       Danio rerio   TVHF---KNFPEQDLLHCSTNSVIEAHFMSCIKEAD-ALKHKGQVINDMQKKDHKQLWMG
 Rattus norvegicus   TVHF---KSFPEKDLLHCPCKDAVEAHFMSCVKEAD-ALKHKSQVINEMQRKDHKQLWMG
   D. melanogaster   TIHF---SKFPEDMLVKLNSKELLESHYMSCLKEAD-VLKHRGLVISAMQKKDHNQLWLG
     S. cerevisiae   RIHLVMGDSLPPTIIPIASSKTQAEKFWFHQWKQVCFILNGSSKAIMSLSVNEARKFWGS
      Mus musculus   LQNDRFDQFWAINRKLMEYPPEENGFRYIPFRIYQTTTERPFIQKLFRP-VAADGQLHTL
      Homo sapiens   LQNDRFDQFWAINRKLMEYPAEENGFRYIPFRIYQTTTERPFIQKLFRP-VAADGQLHTL
        Bos taurus   LQNDRFDQFWAINRKLMEYPAEENGFRYIPFRIYQTTTERPFIQKLFRP-VSTDGQLHTL
        Sus scrofa   LQNDRFDQFWTINRKLIEYPPEENGFRYIPFRIYQTTTERPFIQKLFRP-VAADGQLHTL
     Gallus gallus   LQNDKFEQFWAINRKLMEYPPEDSGFRYIPFRIYQATTERPFIQKLFRP-IASGGQLHTL
       Danio rerio   LQNDKFDQFWAMNRKLMEYPTEEGGFRYIPFRIYQTMSDRPFIQTLFRP-VSSEGQALTL
 Rattus norvegicus   LQND-LTSFG---------PSTGNSWNTLQKKMDFVISLLEYI----RP---------QL
   D. melanogaster   LVNEKFDQFWAVNRRLMEPYGDLESFKNIPLRIY-TDDDFTYTQKLISP-ISVGGQKKSL
     S. cerevisiae   VITRNFQDFIEISNKI-----SSSRPRHIPLIIQTSRTSGTF--RISQPTISMTGVNPTL
      Mus musculus   GDLLREVCPSAVAPEDGEKRSQVMIHGIEPMLETPLQWLSEHLSYPDNFLHISIVP-Q--
      Homo sapiens   GDLLKEVCPSAIDPEDGEKKNQVMIHGIEPMLETPLQWLSEHLSYPDNFLHISIIP-Q--
        Bos taurus   GDLLKEVCPSAVAPEDGEKKNQVMIHGIEPMLETPLQWLSEHLSYPDNFLHISIIP-Q--
        Sus scrofa   GDLLREVCPSAVAPEDGEKKSQVMIHGIEPLLETPLQWLSEHLSYPDNFLHISIVP-Q--
     Gallus gallus   GDLLKDVCPSAITPEDGEKTTQVMIHGIEPMLETPLQWLSEHMSYPDNFLHISIIP----
       Danio rerio   GDLLKELFPAAI--EDEPKKFQVMIHGIEPLLETPIQWLSEHLSHPDNFLHISIIP----
 Rattus norvegicus   NGLSFRSCS--------------------------VLWPQMDSCIP---LEIS-------
   D. melanogaster   ADLMAELSTPV------RRAVGCRTHGIDLHEETQLQWMSEHLSYPDNFLHLSVDY-K--
     S. cerevisiae   KDIEGDILD--VKEGINGNDVMVICQGIEIPWHMLLYDLYSKLRSFDGFLYITLVPIKGG
      Mus musculus   ----PTD
      Homo sapiens   ----PTD
        Bos taurus   ----PTD
        Sus scrofa   ----PTD
     Gallus gallus   ---RPTD
       Danio rerio   ---APSD
 Rattus norvegicus   -------
   D. melanogaster   -----DV
     S. cerevisiae   DKASSEL
 79 
 
 
Figure 13: In vivo phosphorylation of Atg5 at threonine T75. 
(a) Alignment of the protein sequences of Atg5 of the indicated species. Highlighted in grey are the 
potentially conserved phosphorylation sites. (b) Homology analysis of the Atg5 protein sequences of 
the same species as in (a) (c) Atg5-/- MEFs were stably reconstituted either with wildtype Atg5 or a 
mutant in which the threonine T75 is substituted against an alanine. Then, the cells were cultivated for 
30 min in a phospho-deficient medium and subsequently in a 33PO43--containing one. After 4 h the 
cells were harvested, lysed and Atg5 was immunoprecipitated for 4 h. Subsequently, the beads were 
subjected to SDS-PAGE and autoradiography. 
 
The phosphorylation of Atg5 by p38 was already shown in vitro (Keil 2008). To substantiate 
these in silico and in vitro findings and to verify a phosphorylation of Atg5 at the TP binding 
site 75 by p38, an in vivo phosphorylation approach was performed. To this end, 
reconstituted Atg5-/- MEFs (Kuma et al. 2004) either with MYC-tagged wildtype Atg5 or with 
an Atg5 mutant, in which threonine 75 was substituted against an alanine, were used. These 
cells were previously generated (Keil 2008). As expected, the transfection with Gadd45β and 
MEKK4 did not result in a phosphorylation of the phosphorylation-defective Atg5 T75A 
mutant, whereas in the wildtype reconstituted MEFs the incooperated 33P darkened the x-ray 
film at a molecular weight of 35 kDa, the size of free Atg5 (Fig. 13c). Thus, the direct 
phosphorylation of Atg5 by the Gadd45β/MEKK4/p38 pathway could be proven.  
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4.1.5 Atg5 phosphorylation at threonine 75 blocks the autophagic flux 
Overexpressing Gadd45β and MEKK4 in NIH/3T3 cells could clarify the role of the two 
proteins and their connection to the autophagic flux. To further strengthen the point that the 
phosphorylation site T75 of Atg5 is the target of p38 and its phosphorylation exerts a direct 
effect on the autophagic flux, again the Atg5-/- MEFs reconstituted either with wildtype Atg5, a 
T75A mutant with a substitution of threonine against alanine or a T75E mutant, where the 
threonine is substituted against a glutamic acid, were analysed (Fig. 14a). 
 
Figure 14: The effect of loss and gain of function of threonine 75 in Atg5 in MEFs under 
starvation. 
(a) Atg5-/- MEFs were stably reconstituted with wildtype Atg5 or a mutant in which the threonine T75 is 
substituted against a glutamic acid or an alanine, respectively. The cells were transfected with the 
RFP-GFP-LC3 reporter construct and 24 h later either starved in HBSS for 4 h or left untreated. Then, 
the cells were fixed and subjected to confocal microscopy. Bars represent 10 µm. (b) Statistical 
significances were calculated by two-tailed Mann-Whitney test (n=50, mean ± s.d., * P=0.0166, *** 
P<0.0001).  
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The alanine substitution mutant T75A served as a negative control, which could no longer be 
phosphorylated. The T75E mutant mimicked a constant phosphorylation by providing a 
negative charge to Atg5 that imitated its phosphorylated state. With these two controls, the 
cells were transfected with RFP-GFP-LC3 and 24 h post-transfection either starved for 4 h 
with HBSS or left untreated in full medium. Subsequently, the cells were subjected to 
confocal microscopy and 50 pictures per cell type and condition were analysed for 
autophagosome (GFP+) and autolysosome formation (GFP+RFP+) (Fig. 14b). In the wildtype 
situation a slight increase in the number of autophagosomes upon starvation could be 
detected, whereas the number of RFP+ spots stayed the same. As expected, the starvation 
had no effect on the T75E mutant, demonstrating that the phosphorylation of Atg5 or in this 
case its substitution, led to a loss of sensitivity to nutrient conditions in vitro. Not surprisingly, 
the Atg5 T75A mutant showed completely inverted results. Regardless of the nutrition state 
of the cell, the number of autophagosomal (RFP+GFP+) spots was increased in a highly 
statistical relevant manner in contrast to the Atg5 T75E reconstituted cells (P<0.0001) and 
remained that way after starvation. The statistical analysis was calculated with the two-tailed 
Mann-Whitney test (n=50, mean ± s.d.). The same was even more true for the number of 
autolysosomes (RFP+). These numbers were elevated to an even higher level than the 
autophagosomes, being statistical highly significant (P<0.0001), both against the wildtype 
reconstituted and the T75E mutant. Starvation, however, had no significant effect on the 
number of RFP+ spots, as expected. 
In line with the previous results, the T75E mutant also stayed the same, regardless of the 
nutrition state of the cells. However, the absolute numbers were even lower as compared to 
the wild type reconstituted cells. Taken together, these results confirmed the previous 
experiments and proved the function of the phosphorylation site threonine 75 in Atg5. 
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4.1.6 Phosphorylation of Atg5 at threonine 75 does not affect downstream 
localisation of the protein related to lysosomes 
Preceding experiments could identify the phosphorylation of Atg5 at the threonine 75 as a 
key modulator of autophagic flux. Atg5 is known to form a complex with Atg12 and Atg16 and 
this complex mediates the lipidation of Atg8/LC3 during autophagosome formation 
(Mizushima et al. 2001; Komatsu et al. 2001). Upon completion of this task, this 
Atg5-Atg12-Atg16 complex is thought to be recycled from the autophagosomal membrane. 
To confirm or rule out that the phosphorylation of Atg5 at threonine 75 has an impact on the 
localisation of Atg5 after the lipidation of LC3 at the autophagosomal membrane, the 
localisation of Atg5 was determined via confocal microscopy. Again, Atg5-/- MEFs that were 
either reconstituted with wildtype Atg5, the T75A or the T75E mutant were starved for 4 h 
with HBSS or left untreated. Subsequently, the lysosomes were coloured with Lysotracker 
red and the MYC-tagged Atg5 was labelled with an α-MYC antibody in Alexafluor488. As 
controls, Atg5-/- MEFs were treated the same and wildtype reconstituted MEFs were stained 
without the primary antibody but with the secondary Alexafluor488 coupled (Fig. 15b). 
Neither in wildtype reconstituted, Atg5-T75A nor Atg5-T75E reconstituted MEFs a 
colocalisation between Atg5 and Lysotracker red+ spots could be observed (Fig.15 a,c,d). 
This result was consistent regardless of the nutrition state of the cell. These findings strongly 
suggest that the phosphorylation of Atg5 by p38 has no effect on the subcellular localisation 
of the same prior or after exerting its function of lipidation of Atg8/ LC3 at the 
autophagosomal membrane. 
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Figure 15: The phosphorylation state of threonine 75 does not alter the localisation of Atg5 
against lysosomes. 
(a) Atg5-/- mouse embryonic fibroblasts (MEFs) stably reconstituted with MYC-tagged Atg5 were either 
starved or left untreated for 4 h prior fixation. The tag was stained with an anti-MYC antibody (AF488) 
and lysosomes were coloured with Lysotracker red. Subsequently, samples were analysed by 
confocal microscopy. (b) MEFs as in (a) were treated the same but without the anti-MYC antibody. 
Atg5-/- MEFs were treated as in (a) as a control. (c) Atg5-/- MEFs stably reconstituted with an alanine 
for the threonine at amino acid 75 in Atg5 were treated as in (a). (d) Atg5-/- MEFs stably reconstituted 
with a glutamic acid for a threonine at amino acid 75 in Atg5 were treated as in (a).  
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4.1.7 Increased autophagy in Gadd45β-deficient cells upon lipopolysaccharide (LPS) 
stimulation 
A recent publication showed that Gadd45β was induced upon stimulation with LPS (Zhang et 
al. 2005). Additionally, it was reported that autophagy initiation is mediated by Toll-like 
receptor 4 (TLR4) activation (Xu et al. 2007; Sanjuan et al. 2007; Delgado et al. 2009). In 
order to analyse a potential physiological role of the Gadd45β/MEKK4/p38 signalling event in 
the TLR4 pathway, MEFs that were generated from Gadd45β-deficient and their 
corresponding wildtype mice were stimulated with 100 ng/ml LPS for 0.5, 2, 4, 8 and 24 h or 
left untreated, both in the absence and presence of 100 nM bafilomycin A1 for the last 2 h of 
stimulation. 
 
 
Figure 16: Gadd45β  suppresses autophagy upon LPS treatment in MEFs. 
(a) MEFs from wildtype and Gadd45β deficient animals were stimulated in vitro with 100 ng/ml LPS for 
the illustrated time periods. 2 h prior to harvesting, the cells were additionally treated with either 
100 nM bafilomycin A1 or left untreated. Subsequently, cellular lysates were prepared and subjected 
to SDS-PAGE and immunoblotting. The blots were probed for phospho-p38, total p38, Atg5 and LC3. 
Tubulin served as a loading control. Results shown are representative for four independent 
experiments. (b) Quantification of the results shown in (a). The intensities of the LC3-II bands were 
normalised to the tubulin loading control. Data are represented as mean of three independent 
experiments ± s.e.m.  
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Bafilomycin A1 is an inhibitor of vacuolar type H+-ATPases (V-ATPases) in eukaryotic cells 
and blocks the acidification of autophagosomes, thereby preventing autophagosomal 
degradation (Bowman et al. 1988; Yamamoto et al. 1998). Then, the protein extracts were 
subjected to SDS-PAGE and subsequent immunoblot analysis. In the absence of bafilomycin 
A1, almost no Atg8/LC3-I and no phosphatidylethanolamine (PE) conjugated LC3-II was 
detectable. The conversion of LC3-I to PE-conjugated LC3-II marks the membrane 
association of the protein to the autophagosome. By these means, the ratio of LC3-I to LC3-II 
and from LC3-II to a loading control can be used as an indicator of autophagic flux. As a 
consequence, autophagosomes are prone to lysosomal fusion and degradation, a block of 
this step is necessary to draw any valid conclusions (Klionsky et al. 2008). 
In the Gadd45β-/- MEFs, the levels of membrane-associated LC3-II did already increase upon 
LPS stimulation without the inhibition of acidification by bafilomycin A1 treatment (Fig. 16a, 
upper panel). Moreover, when acidification was inhibited, the levels of LC3-II were highly 
increased in Gadd45β-/- MEFs upon stimulation with LPS. Already after half an hour of 
stimulation, the Gadd45β−deficient MEFs showed a high accumulation of LC3-II in contrast 
to the wildtype situation, where larger quantities of the protein only started to pile up after 4 to 
8 h. By correlating the amount of LC3-II protein as determined by semi-quantitative 
immunoblot with the amount of a loading control, e.g. tubulin, it was possible to obtain 
quantitative information about the amount of LC3-II (Fig. 16b). Quantification of the 
abundance of LC3 was measured in three independent experiments and confirmed the 
observed increase in autophagic flux in the Gadd45β-/- situation upon stimulation with LPS. 
The LPS stimulation of MEFs could be shown to have a direct connection to the 
Gadd45β/MEKK4/p38 pathway. Because the mouse embryonic fibroblasts are a model 
system, they do have certain drawbacks. These specific MEFs for example were 
immortalised by the transfection with the Simian Vacuolating Virus 40 Tag (SV40 large 
T antigen). In order to circumvent the possibility that the process of immortalisation has 
influence on the results, primary bone marrow-derived macrophages (BMDMs) were 
generated from wildtype and Gadd45β-deficient mice. To this end, bone marrow cells were 
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isolated out of the tibia and femur and differentiated for 7 days in DMEM containing M-CSF 
(see 2.2.5), (McWhirter et al. 2009). The BMDMs were analysed by FACS with the help of an 
αF4/80 antibody prior to LPS treatment against an unstained control to ascertain the 
differentiation into BMDMs (Fig. 17b).  
 
 
Figure 17: Gadd45β-deficiency enhances LPS-induced autophagy in bone marrow-derived 
macrophages. 
(a) Bone marrow-derived macrophages (BMDMs) from wild type and Gadd45β-deficient mice were 
stimulated in vitro with 100 ng/ml LPS for the indicated time periods. In order to prevent the 
acidification of the autophagosomes and thus LC3-II degradation, half of the cells (lower panel) were 
treated with 100 nM bafilomycin A1 2 h prior to harvesting. Subsequently, cellular lysates were 
prepared and analysed by SDS-PAGE and immunoblotting. The blots were probed for phospho-p38, 
total p38, Atg5 and LC3. β-actin served as a loading control. The results are representative for two 
independent experiments. (b) F4/80 expression of BMDMs prior to LPS treatment, stained with a 
specific, FITC-labelled antibody and subsequent FACS analysis. Grey is the unstained control. 
 
The F4/80 protein is the mouse homologue of the human EGF-like module-containing 
mucin-like hormone receptor-like 1 protein, a member of the adhesion-GPCR family and 
serves as a well-accepted marker for mature macrophages, which derive out of the myeloid 
lineage. 
Subsequently they were stimulated with LPS (see 4.1.7), subjected to SDS-PAGE and 
analysed by immunoblotting. Without blocking the lysosomal degradation with the help of 
bafilomycin A1, neither wildtype nor Gadd45β-deficient BMDMs accumulated LC3-II to a 
LC3-I
LC3-II
`-actin
0 0.5 2 4 8 24 0 0.5 2 4 8 24 LPS [h]
(p)p38
p38
Atg5
LC3-I
LC3-II
`-actin
(p)p38
p38
Atg5
Gadd45  -/-ȕwildtype
un
tr
ea
te
d
 +
ba
fil
om
yc
in
 A
1
a b
F4/80
%
 m
ax
.
%
 m
ax
.
unstained
Gadd45`-/-
Gadd45`+/+
 87 
large extent. In both cases a significant amount of the protein could be detected only after 
24 h of stimulation (Fig. 17a). Importantly, with the use of bafilomycin A1, an accumulation of 
LC3-II could already be detected after 2 h of stimulation in Gadd45β-deficient BMDMs, 
whereas the wild typical cells did not accumulate LC3-II to any significant extent. The data is 
representative for one out of two independent experiments with BMDMs.  
Taken together, the results show that the Gadd45β-MEKK4-p38 pathway controls at least in 
part the TLR4-mediated autophagy in fibroblasts and in macrophages. 
 
4.1.8 Gadd45β  supresses αCD3-mediated autophagy in primary thymocytes 
Schmitz and colleagues could show a high induction of Gadd45b transcript upon TCR 
stimulation in the N15 mouse model for negative selection in the thymus (Schmitz et al. 
2003). As TCR signalling events have recently been shown to exert an impact on autophagy 
(Salmond et al. 2009), thymocytes were stimulated with αCD3 for the indicated time points. 
 
Figure 18: Gadd45β  suppresses αCD3-mediated autophagy in primary thymocytes. 
Thymocytes of wildtype and Gadd45β-/- mice were prepared and subjected to αCD3 treatment for the 
indicated time points with a concentration of 10 µg/ml. 2 h before harvesting, the cells were treated 
with bafilomycin A1 to prevent acidification of the autophagosomes and thus protein degradation. 
Subsequently, cellular lysates were prepared and analysed by SDS-PAGE and immunoblotting. The 
blots were probed for phospho-p38, total p38, Atg5 and LC3. β-actin served as a loading control. The 
mice were littermates and 3-4 weeks of age.  
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The stimulation was done either in the presence or absence of bafilomycin A1 for the same 
reasons mentioned in figure 16 and 17. Depicted is the data with bafilomycin A1. Upon 
prolonged stimulation, the Gadd45β-deficient thymocytes showed an increased abundance 
of LC3-II protein as compared to the wildtype situation (Fig. 18). Here, no accumulation of 
LC3-II could be detected at any timepoint. On the contrary, the Gadd45β-deficient 
thymocytes showed a high increase in LC3-II levels, already apparent after 4 h of stimulation 
and steadily increased up to 24 h of stimulation. Taken together, this experiment 
demonstrated that the Gadd45β-MEKK4-p38 pathway of autophagy downregulation is not 
restricted to LPS stimulation, but is also relevant to other stimuli and cell types. 
 
4.1.9 CD8+ T cells and thymocytes show in vitro an upregulation of GFP-LC3 upon 
PMA/Ionomycin stimulation 
Autophagy is arguably foremost a cell survival mechanism. Recent reports show that both, 
T cell homeostasis and function, also heavily rely on autophagy and its capability of 
degrading unneeded intracellular content (Jia and He 2011) and surface receptor expression 
(Mcleod et al. 2011). Additionally, autophagy was found to regulate energy metabolism 
during effector T cell activation (Hubbard et al. 2010). In order to assess the role of 
autophagy in T cell activation in more detail, thymocytes of GFP-LC3wt/wt, GFP-LC3wt/tg and 
GFP-LC3tg/tg mice were stimulated in vitro with 20 ng/ml PMA and 1 µM Ionomycin for 1.5 or 
3 h (Fig. 19a). Subsequently, the samples were analysed by FACS and subgroups of 
thymocytes were set according to the CD4+/CD8+ distribution, to distinguish CD4+ against 
CD4+CD8+ and CD8+ thymocytes. The stimulation-dependent reduction of CD4+CD8+ 
positive thymocytes could be observed in all 3 genotypes. The frequency of GFP+ cells of all 
3 subgroups and genotypes are shown in Fig. 19b. As expected, wildtype thymocytes 
exerted no GFP signal in either subgroup of thymocytes. In heterozygous GFP-LC3 mice 
(GFP-LC3wt/tg), a GFP+ group, was also absent in CD4+ and CD4+CD8+ double positive 
thymocytes, but a fraction of 6.3% CD8+ cells showed an induction of a GFP signal after 3 h 
of PMA/Ionomycin stimulation. Induction of GFP-LC3 in the CD4+ single positive cells were 
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also absent in the GFP-LC3 homozygous mice (GFP-LC3tg/tg). However, 5.5 % of the 
CD4+CD8+ double positive thymocytes up regulated GFP-LC3 after 3 h of stimulation and, 
more pronounced, 21.0% of the single positive CD8+ thymocytes induced GFP-LC3 after 3 h 
of stimulation. The gating for the spleen was accordingly done to the thymus with the 
exception of double positive cells (data not shown). Here, a very small fraction of CD4+ 
T cells of GFP-LC3wt/tg and GFP-LC3tg/tg mice became GFP+ after 1.5 and 3 h of stimulation, 
2.3% and 4.4%, respectively (Fig. 19c). 
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Figure 19: CD8+ but not CD4+ T cells and thymocytes highly upregulate GFP-LC3 in vitro upon 
PMA/Ionomycin stimulation. 
(a) CD4+CD8+ profile of in vivo stimulated thymocytes of wild type and GFP-LC3 transgenic mice. The 
cells were stimulated with 20 ng/ml PMA and 1 µM Ionomycin for the indicated time periods and 
subsequently analysed by FACS. (b) Depicted are the same cells and gatings as in (a) for either CD4+ 
single positive (upper panel), CD4+CD8+ double positive (middle panel) or CD8+ single positive cells 
(lower panel). The indicated percentages do reflect the amount of GFP-LC3 positive thymocytes after 
3 h of stimulation with PMA/ Ionomycin. (c) The same settings as in (b) for the splenocytes of the 
same mice. (d) A similar panel as in (b) and (c) for the lymph nodes of the same mice. Panel (a)-(d) 
show a representative analysis for two independent experiments. (e) A representative CD8+ 
splenocyte of a GFP-LC3 transgenic mouse after 4 h stimulation with PMA/Ionomycin. Bar represents 
10 µm.  
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Interestingly, a large population within the CD8+ T cells became GFP positive, 54.8% in the 
GFP-LC3wt/tg mice and 69.8% in the GFP-LC3tg/tg mice. As already observed in the thymus, 
the homozygous mice showed a higher increase in the amount of GFP+ T cells as compared 
to the heterozygous ones. This seems to argue in favour of a gene-dose dependency of 
GFP-LC3 induction in heterozygous T cells compared to homozygous ones. For the 
peripheral lymph nodes the same gating strategy was applied as for the spleen and, although 
in reduced numbers the same pattern of GFP+ T cells emerged (Fig. 19d). Again, only very 
few of the CD4+ T cells did show an induction of GFP signal, 2.0% for the heterozygous mice 
and 3.5% for the GFP-LC3tg/tg mice. In line with the previously obtained results of the CD8+ 
T cells population, a larger fraction did become GFP+, 9.0% of the CD8+ T cells of GFP-
LC3wt/tg mice and 18.8% of the homozygous GFP-LC3 transgenic mice. 
Due to the concept of flow cytometry, it is only possible to determine the amount of GFP 
signal per cell, but not its localisation. To proof that the observed increase in GFP signal is 
not due to an increase in autofluorescence but to an accumulation of GFP+ spots in the 
cytoplasm of T cells, splenocytes were sorted according to their expression profile in regard 
to CD4 and CD8 expression. Subsequently, those cells were plated in a live cell-imaging 
chamber pre-coated with Poly-L-Lysine and stimulated under surveillance by a confocal 
microscope. While no CD4+GFP+ splenocytes could be detected upon stimulation, it was 
possible to make pictures of CD8+GFP+ T cells (Fig 19e). Although the cytoplasmic 
compartment is relatively small in T cells, two GFP+ autophagosomal spots could be clearly 
identified within the cell.  
These experiments demonstrate, that upon activation of T cells with PMA/ Ionomycin, CD8+ 
but not CD4+ T cells form autophagosomal spots in the cytoplasm.  
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4.2 The Role of Gadd45β in apoptosis during negative selection in the 
thymus 
4.2.1 General characterisation of Gadd45β -/- mice in comparison to wildtype animals 
Currently there are three different Gadd45β-/- mouse lines (Gupta et al. 2005; Papa et al. 
2004; Lu et al. 2004). The Gadd45β-/- mouse generated in the laboratory of Dan Liebermann 
was used in this work to elucidate the role of Gadd45β in apoptosis and autophagy (Gupta et 
al. 2005). So far, no publication has analysed the lymphoid compartment of these knockout 
mice in detail. Thus, in order to ascertain that the knock out of the Gadd45β gene had no 
unknown side effects and to characterise the compartment properly, the composition of the 
T cell compartment in the mouse was analysed in detail.  
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Figure 20: General analysis of thymocytes from wildtype, Gadd45β+/- and Gadd45β -/- mice. 
(a) Representative pseudo-colour dot blots of wildtype, Gadd45β+/- and Gadd45β-/- mice. Depicted are 
all three genotypes and the distribution in a CD4+/CD8+ profile in the thymus, spleen, peripheral lymph 
nodes and mesenteric lymph nodes. (b) Scatter dotblot diagrams of the absolute number of cells of 
the different lymphatic organs depicted in (a). All mice were littermates and 6 weeks of age. Data from 
4 independent experiments are shown. Statistical significances were calculated by two-tailed Mann-
Whitney tests (n=3, mean ± s.d.).  
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In figure 20a representative FACS analysis of major lymphatic organs: thymus, spleen, 
peripheral and mesenteric lymph nodes are depicted. No alterations in the CD4+/CD8+ profile 
could be found in any of the depicted organs. The total number of T cells in the lymphatic 
organs is shown in figure 20b. Here, no statistical significant differences could be observed 
as well. In order to rule out any misbalances in the amount of total CD4+ and CD8+ T cells, 
these values were calculated for each organ as well. Again, no statistically significant 
differences could be observed in the amount of total CD4/8+ T cells (Figure 21). 
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Figure 21: Absolute numbers of cells in respect to their cell surface marker expression in 
different lymphatic organs. 
(a) Scatter dotblot diagrams of the absolute number of CD4+ cells of the different lymphatic organs 
depicted in figure 11. (b) Scatter dotblot diagrams of the absolute number of CD8+ cells of the different 
lymphatic organs depicted in figure 11. All mice were littermates and 6 weeks of age. Data from 4 
independent experiments are shown. Statistics were calculated by two-tailed Mann-Whitney test (n=3, 
mean ± s.d.).  
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Along these lines, the percentages of CD4+ and CD8+ T cells relative to the whole population 
of T cells were analysed (Fig. 22 a, b). 
 
Figure 22: Percentages of cell surface marker expression in different lymphatic organs. 
(a) Scatter dotblot diagrams of the percentage of CD4+ cells of the different lymphatic organs depicted 
in figure 11. (b) Scatter dotblot diagrams of the percentages of CD8+ cells of the different lymphatic 
organs depicted in figure 11. All mice were littermates and 6 weeks of age. Data from 4 independent 
experiments are shown. Statistics were calculated by two-tailed Mann-Whitney test (n=3, mean ± s.d.).  
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Interestingly, there were no general tendencies consistent in the CD8+ compartment, 
whereas the percentage of CD4+ T cells was decreased in all lymphatic organs of Gadd45β+/- 
and Gadd45β-/- mice analysed, although not statistically significant. 
 
4.2.2 Gadd45β -/- mice have a misbalance in the ratio of CD4+ effector versus 
regulatory T cells 
The whole Gadd45 protein family is strongly associated with autoimmunity. Gadd45β  
deficiency for instance is described to exacerbate experimental autoimmune 
encephalomyelitis (EAE) and also to play a role in the appearance of autoimmune 
lymphoproliferative syndrome and systemic lupus erythematosus in a Gadd45β/γ double 
deficient situation (Liu et al. 2005). Regulatory T cells were first described in 1971 and are 
subject of intense research today (Gershon and Kondo 1971).  
 
Figure 23: Intracellular Foxp3 staining in wildtype and Gadd45β -/- mice in different lymphatic 
organs. 
Representative pseudo-colour dot blots of the same wildtype, Gadd45β+/- and Gadd45β-/- mice shown 
in 11. Depicted are all three genotypes and the distribution in a CD4+/Foxp3+ profile in the thymus, 
spleen, peripheral lymph nodes and mesenteric lymph nodes.  
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To assess the possible role of Gadd45β in autoimmunity, the absolute number and 
composition in terms of frequency of the CD4+ T cell repertoire of Gadd45β+/+, Gadd45β+/- 
and Gadd45β-/- mice in the thymus, spleen, peripheral lymph nodes and mesenteric lymph 
nodes was analysed via FACS. The frequency of regulatory T cells as determined by Foxp3 
staining in the CD4+ compartment was altered. Figure 23 shows a representative FACS 
profile of pregated CD4+ T cells, intracellularly stained for Foxp3. In all four organs, the 
frequency of Foxp3+ T cells was highly statistically significantly elevated in the Gadd45β-/- 
mice (Fig. 24a).  
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Figure 24: The percentages but not the absolute numbers of CD4+Foxp3+ regulatory T cells are 
increased in Gadd45β -/- mice. 
(a) Scatter dotblot diagrams of the percentage of CD4+Foxp3+ cells of the different lymphatic organs of 
the mice depicted in figure 11. (b) Scatter dotblot diagrams of the absolute numbers of CD4+Foxp3+ 
cells of the different lymphatic organs depicted in figure 11. All mice were littermates and 6 weeks of 
age. Data from 4 independent experiments are shown. Statistics were calculated by two-tailed Mann-
Whitney test (n=3, mean ± s.d.).  
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Interestingly, the absolute numbers of these cells were not elevated in the same way 
(Fig. 24b). As already stated in chapter 4.2.1, the frequency of CD4+ T cells also showed a 
slight decrease in all organs, though not statistically significant (Fig. 22a). This experiment 
shows, that the number of CD4+ effector cells is reduced in Gadd45β-/- mice and in this way, 
the number of Foxp3+ regulatory T cells lay out a larger piece of the overall composition of 
CD4+ effector T cells in the Gadd45β-deficient situation. 
 
4.2.3 Gadd45β-dependent differences in apoptosis of double positive (CD4+CD8+) 
thymocytes 
In an array analysis of a model organism of negative selection in the thymus, Gadd45β was 
identified as the most highly induced gene upon triggering of the TCR (Schmitz et al. 2003). 
Then, previous work could show that Gadd45β expression in a double positive (CD4+CD8+) 
thymocyte cell line is strongly connected to apoptosis. Upon overexpression with a retroviral 
vector containing Gadd45β, these double positive cells were more sensitive to αCD3 induced 
apoptosis than their uninfected control group (Keil 2008). To confirm this data in an approach 
more closely related to the in vivo situation, primary thymocytes from Gadd45β-deficient 
animals and their wildtype littermates were stimulated with different apoptotic stimuli to 
induce cell death. The double positive thymocytes of this in vitro approach were 
subsequently stained with AnnexinV/7AAD to discriminate between living and apoptotic cells 
(Fig. 25a). 
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Figure 25: Double positive (CD4+CD8+) Gadd45β -/- thymocytes show different apoptotic 
behaviour upon T cell receptor stimulation, but not to other stimuli. 
(a) 1x106 thymocytes were ex vivo cultured for 16 h with the indicated concentrations of 
dexamethasone. Subsequently, they were stained for CD4, CD8 and apoptosis was determined with 
an AnnexinV/7AAD staining. (b) Statistic analysis of the specific apoptosis rate of the results 
determined in (a). Additional stimuli were applied with the indicated concentrations. For cytokine 
deprivation, the cells were cultured for the indicated time period without any stimulus. All mice were 
littermates and 6 weeks of age. Statistical significances were calculated by two-tailed Mann-Whitney 
tests (n=3, mean ± s.d.).  
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The analysis is representative for all apoptotic stimuli applied. The viability of the CD4+ CD8+ 
thymocytes towards different stimuli, being it intrinsic ones like dexamethasone or the 
phorbol ester PMA or extrinsic, like the αFas antibody, showed no significant differences 
(Fig. 25b). Also the complete lack of stimulation by cytokine deprivation led to comparable 
results between wildtype and Gadd45β-/- mice. When stimulated with αCD3, the CD4+CD8+ 
double positive thymocytes showed a deviant behaviour. In the Gadd45β-/- situation, the cells 
seemed to be protected against apoptosis. Especially at lower concentrations of under 
2 µg/ml, which simulate endogenous stimulation by MHC much closer than high 
concentrations of 10 µg/ml, the viability of double positive Gadd45β-/- thymocytes was 
increased. 
4.2.4 The Vβ  repertoire of Gadd45β
-/- mice shows no statistical significant difference 
to wildtype mice 
Viral superantigens in association with MHC class II molecules specifically bind to certain Vβ 
elements of the TCR and induce apoptosis in large fractions of immature CD4+CD8+ double 
positive thymocytes bearing these Vβ elements (Fairchild and Rosenwasser 1993). 
Analysing the Vβ repertoire of Gadd45β
-/- against Gadd45β+/+, it is possible to assess the 
influence of these virals superantigens on the process of negative selection.  
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Figure 26: T cell receptor Vβ  repertoire in Gadd45β-sufficient and deficient mice shows no 
coherent differences. 
(a) Representative pseudo-colour dotblots of a CD4/CD8 staining with subsequent analysis of the 
respective subset with a Vβ-specific, FITC labelled antibody. (b) Thymi of 5 week old littermates were 
stained for the most prominent Vβ subtypes and were subsequently analysed by FACS. The upper 
panel shows a pregate on CD4+ T cells. (c) The middle panel shows the same experiment as in (a), 
but with a pregate on CD8+ T cells. (d) The lower panel shows the same experiment as in (a) but with 
a pregate on CD4+CD8+ double positive thymocytes (b)-(d) Statistics were calculated by two-tailed 
Mann-Whitney test (n=3, mean ± s.d.), graphs show two independent experiments.  
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To test for differences in the Vβ repertoire of the TCR in these mice, an array of antibodies 
against different β-chains was used for flow cytometrical analysis: the whole panel is listed in 
chapter 2.6.3. In the thymus, CD4+, CD8+ and CD4+CD8+ thymocytes were analysed 
separately, in the spleen the CD4+ and the CD8+ compartment (Fig. 26a-c). In no 
compartment of any of the two organs a consistent difference could be found, arguing that 
viral superantigens do not seem to play a role in the negative selection in these mice. 
Therefore, it can be concluded that superantigen-induced negative selection is independent 
of Gadd45β. 
 
4.2.5 Decreased negative selection in vivo in Gadd45β -/- mice 
αCD3 injection into Gadd45β-/- and wildtype mice suggested an in vivo role of Gadd45β in 
negative selection in the thymus (Keil 2008). However, as αCD3 is not found under 
physiological conditions in an organsim and can also induce a cytokine storm, this approach 
is a rather crude model for negative selection. Thus, another stimulus, which can trigger 
exclusively the TCR, is necessary to confirm this data. In order to generate such a model 
system, an N15 TCR transgenic RAG2-/- H-2b (N15) mouse was bred with the Gadd45β-/- one 
in order to generate a mouse with a monoclonal TCR repertoire, which can be easily 
triggered and is deficient for Gadd45β. Subsequently, this mouse was injected the VSV8 
peptide, triggering specifically the TCR and inducing negative selection (Ghendler et al. 
1998). N15 mice served as a control group, which were Gadd45β-proficient (Fig. 27a). The 
data shown is representative for at least 3 animals per group. Upon injection with PBS, both 
CD4/CD8 profiles did remain identical, whereas 24 h post injection with VSV8 peptide, the 
Gadd45β-proficient animals showed a high increase in CD4-CD8- double negative 
thymocytes (61.9%) and a decrease in CD4+CD8+ double positive thymocytes (16.5%), 
whereas in the Gadd45β-/- animals a large pool of CD4+CD8+ double positive thymocytes 
(56.1%) remained. 48 h post injection of the animals, the frequency of CD8+ single positive 
thymocytes in the Gadd45β+/+ mice had risen from 11.3% after 24 h to 25.4%. In the same 
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time this compartment had grown to 38.4% in the Gadd45β-/- animals. In order to determine 
whether the CD8+ thymocytes were mature ones and able to leave the thymus afterwards, 
the expression of heat-stable antigen (HSA, CD24) was controlled (Kishimoto and Sprent 
1997) (Fig. 12e). Both, in the Gadd45β-proficient as in the Gadd45β−deficient situation, the 
maturity of the CD8+ thymocytes was increased 24 and 48 h post injection as compared to 
CD4+CD8+ double positive thymocytes. 
 
Figure 27: Gadd45β-deficiency in thymocytes results in increased positive selection. 
(a) N15H-2b mice and N15H-2bxGadd45β-/- mice were injected into the tail vain with 25 µg VSV8 
peptide for 24, 48 h or with PBS as a control. Representative pseudo-colour dotblots of CD4/CD8 
profiles are depicted. Numbers indicate CD4+CD8+ double positive, CD8+ single positive or CD4-CD8- 
double negative thymocytes. The mice were 3 weeks old. (b) Representative histogram analyses of 
the expression of CD69 on CD4+CD8+ double positive thymocytes upon challenge with VSV8 peptide.  
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This observation was true for all animals, as can be seen in the statistical evaluation 
(Fig. 28). These observations could also be validated in absolute numbers of CD8+ 
thymocytes, where interestingly only 48 h post injection with VSV8 peptide the numbers were 
higher than in the wildtype (Fig. 28b).  
 
 
Figure 28: Statistic analysis of frequencies and absolute numbers of wildtype and Gadd45β-
deficient mice upon VSV8 challenge. 
(a) Statistical analysis of CD8+ thymocyte frequencies. (b) Statistical analysis of absolute numbers of 
CD8+ thymocytes. (c) Statistical analysis of CD4+CD8+ thymocyte frequencies. (d) Statistical analysis 
of absolute numbers of CD4+CD8+ thymocytes. (a)-(d) show statistics of the same experiment as in 
Figure 18. Statistical significances were calculated by two-tailed Mann-Whitney tests (n=3-7, mean ± 
s.d., * P=0.0106, ** P<0.0079).  
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The total numbers of CD4+CD8+ double positive thymocytes were also higher in the 
Gadd45β-deficient situation. Here, 24 h post stimulation with VSV8 peptide, an increased 
population of thymocytes retained a double positive phenotype (Fig. 28d). 
 
The comparison of the maturation status of Gadd45β-deficient with wildtype thymocytes 
revealed no differences, showing that wildtype and Gadd45β-deficient thymocytes are 
equally mature when they migrate to the periphery (Fig. 29a) 
Of note, CD69 is not only described as an activation marker of T cells, but also to be induced 
during the process of negative selection (Brändle et al. 1994). Indeed, a slight increase in 
CD69 expression in Gadd45β-deficient double positive thymocytes could be verified 
(Fig. 29b).  
 
 
Figure 29: Expression of surface markers on T cells of N15H-2b and N15H-2bxGadd45β -/- mice. 
(a) Representative histogram analyses of the expression of CD24 on CD8+ thymocytes in N15H-2b 
and N15H-2bxGadd45β-/- mice upon different time points of VSV8 peptide stimulation. (b) 
Representative histogram analyses of the expression of CD69 on CD4+CD8+ double positive 
thymocytes upon challenge with VSV8 peptide. (c) Representative histogram analyses of the 
expression of CD5 on CD4+CD8+ double positive thymocytes upon challenge with VSV8 peptide. (d) 
CD5/CD69 contour-blots of 48 h VSV8 peptide stimulated thymocytes shown in (c).  
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Additionally, the expression of CD5 in immature, CD4+CD8+ double positive thymocytes is 
reported to be associated with positive selection (Li and Page 2001). The FACS analysis for 
this marker could show a second population in CD4+CD8+ thymocytes, which have 
downregulated the marker substantially (Fig. 29c). A contour-blot of CD69 plotted against 
CD5 expression revealed a significant second population in the Gadd45β-deficient 
thymocytes, which are less positive for CD69 and CD5. 
To verify the expression levels of Gadd45β in the thymus during the process of negative 
selection, samples of the thymi were taken and analysed via quantitative real-time 
polymerase chain reaction (qRT-PCR). As described in the literature, Gadd45β was highly up 
regulated (72-fold) after TCR stimulation (Schmitz et al. 2003). 
 
Figure 30: qRT-PCR of VSV8-stimulated N15 H-2b and N15 H-2b x Gadd45β -/- mice. 
Bar graph of a qRT-PCR of Gadd45β-induction upon VSV8 stimulation of Gadd45β-deficient and 
wildtype N15 H-2b mice. The samples were taken from animals of the same experiment as in figure 
27-29. 
 
As a consequence from this experiment, it can be stated that Gadd45β−deficiency leads to 
defect in negative selection in the thymus, resulting in increased numbers of mature, CD8+ 
single positive T cells. 
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5. Discussion 
5.1 Autophagy-regulation by Gadd45β 
5.1.1 Molecular aspects of the Gadd45β-MEKK4-p38 pathway 
Mitogen-activated protein kinases (MAPKs) are important regulators of cellular events, such 
as proliferation, differentiation, immunity and cell death (Krishna and Narang 2008). 
Post-translational modifications in general allow fast reactions to alter physiological settings, 
as the time necessary for translation and transcription can be disregarded. In respect to 
autophagy, the role of post-translational modifications has already been reported for a 
number of different kinases and their targets, for example ULK1/2, Vps34 and mTOR 
(Sarbassov et al. 2005; Ganley et al. 2009; Proikas-Cezanne et al. 2004). The c-Jun 
N-terminal protein kinase (JNK) for instance was shown to phosphorylate Bcl-2. 
Consequently, Beclin 1 is released from the complex and is able to initiate autophagy in 
unison with Vps34 (Pattingre et al. 2009; Wei et al. 2008). The extracellular-signal-regulated 
kinase (ERK) was also found to interact with a major autophagy-regulating protein, mTOR 
(Wang et al. 2009). The actual details of ERK, which acts on mTOR, are not as well 
elucidated as for JNK. Although these and other studies have already provided a great deal 
of insight into post-translational modifications in the initiation phase of autophagy, little is 
known about their role at later time points during the autophagic flux. 
As mentioned earlier, Gadd45β was found to directly interact with the MAPK/ERK kinase 
kinase (MEKK4) and MAP kinase kinase (MKK)7 (Papa et al. 2004; Takekawa and Saito 
1998). In this regard, Gadd45β was shown to exert opposing functions: on the one hand the 
interaction with MKK7 inhibits JNK activation (Papa et al. 2004), while on the other hand the 
interaction with MEKK4 activates JNK and p38 (Takekawa and Saito 1998). This dual role of 
Gadd45β proofs the importance of MAPK signalling. 
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Previous work in our lab already showed a Gadd45β-dependent translocation of 
phosphorylated p38 to distinct cytosolic spots, that were identified as autophagosomes (Keil 
2008). Therefore, one aim of this study was to proof the direct interaction of p38 with its 
target protein, Atg5. Indeed, upon overexpression of Gadd45β together with MEKK4 in 
mouse embryonic fibroblasts (MEFs), the number of GFP-LC3 positive dots was highly 
statistically significantly increased (Fig. 10a+b). Interestingly, overexpression of MEKK4 
alone did not elevate the number of GFP-LC3 puncta at all, as compared to the empty vector 
control. This can be explained by the fact that Gadd45β was found to be only minimally 
expressed under steady-state conditions in most tissues (Zhang et al. 1999). Therefore, in 
the absence of Gadd45β, MEKK4 is in a closed confirmation and is, thus, unable to exert its 
function (Mita et al. 2002). The fact that GFP-LC3 puncta formation is increased in 
Gadd45β-transfected MEFs, further adds proof to this theory. As expected, overexpression 
of both Gadd45β and MEKK4 resulted in the highest number of intracellular GFP+ dots. 
The results from this experiment clearly demonstrated that Gadd45β is the limiting factor in 
this newly found connection between Gadd45β, MEKK4 and p38. Along these lines, the 
double transfection of Gadd45β and MEKK4 resulted in increased autophagosome numbers, 
though this was starvation-independent, and no increase in autolysosome numbers (Fig 11). 
These results strongly argue in favour of a block in the autophagic flux and rules out the 
possibility of an increased autophagosome formation. The analysis of p38α–deficient MEFs 
further supports the suggested Gadd45β-MEKK4-p38 pathway (Fig. 12). 
It remains unknown why the p38 wildtype MEFs show a decrease in autophagosome as well 
as in autolysosome numbers. The MEFs were obtained from Dr. Angel Nebrada, (Porras et 
al. 2004) and were immortalised either by retroviral infection or by simian virus 40. This may 
be a reason for the aberrant reaction to HBSS-induced starvation. Still, the fact that 
p38α-deficient MEFs show such a clear difference compared to wildtype cells undermines 
the importance of p38 in autophagy. 
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The fact that the relevant phosphorylation site in Atg5 at the threonine T75 is conserved from 
yeast to men suggests that the phosphorylation of Atg5 is an important mechanism in limiting 
autophagy in all species (Fig. 13a+b). The in vivo phosphorylation of Atg5 in wildtype but not 
in phosphorylation- defective mutant MEFs by overexpression of Gadd45β and MEKK4 could 
be shown by a radioactive labelling in vivo (Fig. 13c). Using this method, the phosphorylation 
of an Atg protein, involved in the Atg12 conjugation system, was shown for the first time. The 
importance of T75 in the Atg5 protein was observed by mutation of the phosphorylation site: 
A T75A-expressing mutant, in which the site in question could no longer be phosphorylated, 
which resulted in a drastic increase in autophagosome and autolysosome abundance with 
and without starvation conditions (Fig. 14a+b). Interestingly, the phosphorylation state of 
Atg5 did not have any consequences for the cellular localisation of Atg5, thus a secondary 
spatial effect due to an altered Atg5 localisation can be ruled out (Fig. 15). Surprisingly, a 
recent report showed that a protein called tectonin beta-propeller repeat containing 1 
(TECPR1) co-localises with the Atg12-Atg5 conjugate after autophagosomal completion 
(Chen et al. 2012). Along these lines TECPR1 was also reported to be crucially involved in 
the maturation of autophagosomes to autolysosomes. If TECPR1 is a key factor in 
Atg12-Atg5-dependent fusion of autophagosomes with lysosomes, it could be the 
mechanism by which phosphorylated Atg5 is inhibiting the autophagosomal fusion. However, 
it has long since been established that Atg12-Atg5 disassociates from the autophagosomal 
membrane directly after membrane closure, which is in accordance with the results of this 
thesis (Fig. 15) (Mizushima et al. 2001). Thus, the molecular details and a possible 
connection to the Gadd45β-MEKK4-p38 pathway has to be investigated. Moreover, Chen 
and colleagues used an U2OS-TR inducible cell line with a shRNA knockdown of TECPR1 
(Chen et al. 2012). Whether the observed differences in autophagic behaviour are also 
relevant in other cell lines or, most interestingly, in primary cells, remains to be analysed. 
Taken together, these results demonstrate that Gadd45β and MEKK4 act together on p38 
and direct it to the autophagosomal membrane. There, it phosphorylates Atg5 at the 
threonine 75, resulting in the block of autophagosomal and lysosomal fusion (Fig. 31). Along 
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these lines, autophagosomes accumulate and this results in the increased number of 
GFP-LC3 dot-like structures that could initially be identified. 
 
Figure 31: Schematic representation of the role of Gadd45β-MEKK4-p38 pathway in Atg5 
phosphorylation and autophagic flux. 
I. Steady state conditions: A fraction of the intracellular Atg5 pool is phosphorylated, and a 
normal autophagic flux is established. II. Gadd45β and MEKK4 act on p38 and guide it to the 
autophagosomal membrane, where it phosphorylates Atg5, thus inhibiting autophagosomal 
maturation. III. In a Gadd45β-deficient situation p38 does not phosphorylate Atg5, which 
results in an increased autophagosomal activity. 
 
Recently, Webber and colleagues could identify p38-interacting protein (p38IP) as an 
interaction partner of Atg9. They demonstrated that active p38 sequesters p38IP away from 
Atg9 and in this way indirectly downregulates autophagy (Webber and Tooze 2010). 
However, Webber and colleagues did not look for the kinase activity of p38 and, as a 
consequence, were not able to rule out the possibility of a competition between p38 and 
Atg9. Therefore, the post-translation modification of Atg5 by Gadd45β-MEKK4-p38 is the first 
direct modification of an Atg-protein described so far that is not involved in the initiatory 
phase of autophagy but in its progression.  
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5.1.2 The physiological role of the Gadd45β-MEKK4-p38 pathway 
The discovery of this new post-translational modification of an Atg-protein involved in 
autophagosomal maturation leads to the question whether this new pathway has any 
physiological relevance. Previous reports have shown that Gadd45β is induced in vivo upon 
injection of lipopolysaccharide (LPS) into mice (Zhang et al. 2005). Additionally, autophagy is 
beginning to emerge as a topic also relevant for innate immunity. In a number of publications, 
it was shown that triggering of the Toll-like receptor (TLR)4 resulted in increased levels of 
autophagy (Xu et al. 2007; Sanjuan et al. 2007; Delgado et al. 2009). Along these lines, 
Gadd45β−deficient and wildtype MEFs were stimulated with LPS with or without bafilomycin 
A1. In the Gadd45β-/- MEFs, LC3-II was increased compared to the wildtype controls. This 
was true for untreated cells as well as for cells that were subjected to bafilomycin A1 
treatment, although the increase in LC3-II abundance was much more apparent in the 
treated cells (Fig.16). In order to rule out the possibility that the differences between wildtype 
and Gadd45β-deficient cells was an artefact of the immortalisation process of the MEFs, the 
experiment was repeated with bone marrow-derived macrophages (BMDMs) (Fig. 17). As 
shown in MEFs, the Gadd45β-deficient BMDMs also showed an increase in LC3-II protein 
abundance after treatment with LPS and bafilomycin A1. The increase in autophagy due to 
LPS stimulation is not without reason, as LPS is part of the bacterial outer membrane. It 
functioned as a substitute for a gram-negative bacterium, such as Shigella or Salmonella, in 
this experiment. Among others, these bacteria serve as well-characterised model pathogens 
(Ogawa et al. 2005; Birmingham et al. 2008). However, whether autophagy is able to help in 
bacterial clearance or not is also largely dependent on the pathogen itself. With Listeria 
monocytogenes, Rich and colleagues could already demonstrate in 2003 that autophagy 
plays a pivotal role in the intracellular clearance of bacteria in macrophages (Rich et al. 
2003). Although this pathogen is gram-positive another group could demonstrate Atg5-
dependency of autophagosomal clearance of Streptococcus pyogenes (Nakagawa et al. 
2004). Other bacteria, such as Mycobacterium tuberculosis, were found to be subjected to 
autophagosomal degradation (Gutierrez et al. 2004), indicating that autophagy is a major 
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defence mechanism against bacterial invasion. Along these lines, the Gadd45β-MEKK4-p38 
pathway could be implicated in the downregulation of autophagy after the clearance of the 
pathogen. The importance of autophagy downregulation after an acute activation phase is 
just as important as the upregulation of autophagy at the beginning, in order to prevent the 
cell from self-digestion (Poels et al. 2012). 
Schmitz and colleagues could identify Gadd45β in a screening experiment of negative 
selection in the thymus (Schmitz et al. 2003). Here, Gadd45β was the most upregulated 
gene. Interestingly, recent studies were able to link autophagy to T cell receptor (TCR) 
signalling (Paul et al. 2012). The study could show the selective sequestration of the adapter 
protein Bcl-10 to autophagosomal degradation, resulting in a weakened NF-κB activation. 
Upon triggering of the TCR, Gadd45β-deficient thymocytes showed increased levels of 
LC3-II in comparison to wildtype thymocytes (Fig 18). This was only true after bafilomycin A1 
treatment: unmanipulated thymocytes did not show such increase in the expression levels of 
LC3-II (data not shown). These results demonstrate that the inhibiting effects of the 
Gadd45β-MEKK4-p38 pathway are not limited to certain stimuli or cell types, but seem to 
influence the autophagic machinery generally and in all cell types. This implication could 
become even more important when considering the emerging role of autophagy in T cells. As 
discussed earlier, recent studies could show that autophagy has numerous implications in 
the homeostasis, immunity and energy metabolism of T cells (Hubbard et al. 2010; Pua et al. 
2007; Leavy 2008; Jia and He 2011; Walsh and Bell 2010). Why autophagic levels, as 
measured by GFP-LC3 fluorescence, differ between diverse T cells subsets (Fig. 19) is not 
yet clear and further experiments need to be performed. Additionally, the GFP-LC3 reporter 
mice that were used for this experiment were created with an EGFP-LC3 cassette whose 
expression is driven by a cytomegalovirus immediate-early (CMVie) enhancer and chicken β-
actin (CAG) promoter (Mizushima 2009). Thus, although the expression of the transgene 
should be equal in all tissues due to the β-actin promoter, a promoter-driven effect cannot be 
totally disregarded. Therefore, additional experiments need to be performed, which do not 
 115 
rely on the transgene as a means to detect autophagy, such as SDS-PAGE and 
immunoblotting for LC3-conversion. 
Interestingly, these results are in contrast to a study of Atg5-/- T cells, where Pua and 
colleagues were able to find an overall decrease in thymic cellularity, but no differences 
between the individual T cell subsets (Pua et al. 2007). However, CD8+ effector T cells are 
known to undergo dramatic metabolic changes upon activation, such as enhanced glycolysis, 
glucose and glutamine uptake. This would confirm the role of autophagy in T cells upon 
activation. In a recent study of activated Atg7-/- T cells, the autophagosomal cargo was 
mainly comprised of cytosolic contents, delivering energy for the T cell as opposed to resting 
T cells, where also mitochondria were included into the degradation (Hubbard et al. 2010). 
Interestingly, these changes in T cell metabolism are also MAPK dependent (Carr et al. 
2010; Marko et al. 2010). These findings emphasise the link of MAPK signalling and T cell 
metabolism, where the Gadd45β-MEKK4-p38 signalling might also play an important role. 
Moreover, recent studies could link mTOR activation to TCR signalling (Salmond et al. 2009). 
Thus, the breeding of Gadd45β-deficient mice to GFP-LC3 reporter mice could help to further 
elucidate the function of Gadd45β specifically in autophagy in T cells. 
So, apparently the Gadd45β-MEKK4-p38 pathway exerts an important physiological role in 
dampening the autophagic response after activation by a variety of different stimuli. 
 
5.2 Gadd45β and apoptosis of developing T cells 
5.2.1 The impact of Gadd45β−deficiency on autoimmunity 
Gadd45β was found to have numerous implications in apoptosis induction and also in its 
inhibition (Papa et al. 2007; Gupta et al. 2006; Takekawa and Saito 1998). However, a 
possible role of Gadd45β-deficiency in T cells in regard to apoptosis was not yet 
characterised for the Gadd45β-/- mouse generated in the laboratory of Dan Liebermann 
(Gupta et al. 2005). Although there are reports that proof the Gadd45β-MEKK4 pathway to 
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be required for adequate cytokine production by CD4+ helper T cells, no coherent analysis of 
T cell populations in Gadd45β-deficient mice compared to wildtype has been done (Yang et 
al. 2001; Liu et al. 2005; Chi et al. 2004). Surprisingly, this is also true for the CD4+Foxp3+ 
regulatory T cells, although Gadd45β and Gadd45γ double-deficiency was demonstrated to 
have a severe autoimmune phenotype (Liu et al. 2005), and Gadd45β has been shown to be 
a target of the master transcription factor of regulatory T cells (Tregs), Foxp3 (Marson et al. 
2007). The steady-state observations of Gadd45β-deficient mice compared to wildtype 
littermates revealed a statistically relevant increase of CD4+Foxp3+ T cells in terms of 
frequency (Fig 24a). However, this could not be confirmed by absolute numbers of these 
cells (Fig 24b), so that the higher frequency of these cells in Gadd45β-deficient mice is due 
to a reduction in CD4+ effector T cells (Fig 22a). At first glance this observation is a 
contradiction to the results of other groups: If Gadd45β-deficiency leads to a decrease in 
CD4+ effector T cells, than why are Gadd45β-/- mice more prone to autoimmunity? The study 
of Liu and colleagues only determined the absolute number of splenocytes of the Gadd45β-/- 
and Gadd45β-/-/Gadd45γ-/- mice and not the absolute numbers of the different subsets (Liu et 
al. 2005). Moreover, Liu and colleagues did not include a Foxp3-staining into their analysis of 
infiltrated leukocytes (Liu et al. 2005). Therefore, they declared CD4+CD25+ T cells as 
activated effector cells. However, these cells show a reduced CD4+ expression when 
compared to CD4+CD25- T cells, a characteristic for Tregs (Sakaguchi et al. 1995). 
Additionally, the observations were made in a different knockout mouse than the one that led 
to the observations in this work. Most importantly however, Liu and colleagues used a 
peptide derived of the myelin oligodendrocyte glycoprotein (MOG) to trigger an immune 
response that leads to experimental autoimmune encephalomyelitis (EAE) as opposed to the 
steady-state conditions that were used in this work. In order to proof a functional relevance of 
the decreased absolute numbers of CD4+ effector T cells and the resulting increased 
frequencies of CD4+Foxp3+ Tregs, comparable conditions have to be applied. Along these 
lines, the Gadd45β-deficient mouse used in this thesis should be subjected to MOG and 
resulting EAE. Subsequently, the same analysis has to be performed again. This should 
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reveal whether the autoimmune phenotype is due to a more rapid expansion of Gadd45β-/- 
T cells compared to wildtype ones or not. Of note, the concentration of anti-nuclear 
antibodies (ANAs) in the serum of Gadd45β-deficient mice of high age (10 months) was 
comparable to wildtype mice (data not shown). Additionally, the Gadd45β-dependent 
demethylase activity could be the reason why Gadd45β-deficient mice are more prone to 
autoimmunity than the corresponding wildtype animals. The involvement of Gadd45β in 
demethylation is well described: An overexpression of Gadd45α led to increased 
demethylation in Danio rerio, while the silencing of the whole Gadd45 gene family reduced it 
(Rai et al. 2008). As described earlier, the methylation status of the Treg specific 
demethylated region (TSDR) in Tregs is important for maintenance of the 
immunosuppressive phenotype of these cells (Floess et al. 2007; Polansky et al. 2008). 
Thus, Tregs and conventional CD4+ T cells from Gadd45β-deficient mice were analysed for 
the methylation state of the TSDR. These results were then compared to the results from 
wildtype animals (data not shown). The TDSR of Gadd45β-/-Foxp3+ Tregs was normally 
demethylated and the methylation of naïve CD4+CD62L+ T cells was comparable to the 
wildtype animals. Therefore, the reported demethylation activity of Gadd45β seems to have 
no impact on the Foxp3 locus and, thus, on Treg lineage stability (Sen et al. 2010). 
In conclusion it can be said that Gadd45β-deficiency alone seems not to have a severe 
impact on the autoimmune-phenotype of mice. Both studies of methylation and of 
autoimmunity discussed earlier also had a look at mice deficient for at least two different 
Gadd45 family members (Liu et al. 2005; Rai et al. 2008). When taking into consideration 
that the Gadd45 family members are conserved among each other (Ashford and Porter 
1962; Tamura et al. 2012; Liebermann and Hoffman 2008), a certain degree of redundancy 
seems to play a role. Thus, in order to analyse the impact of Gadd45-deficiency in respect to 
autoimmunity, a situation of wildtype against double- or triple-deficiency of the Gadd45 family 
needs to be analysed.  
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5.2.2 The role of Gadd45β  in apoptosis in the context of negative selection in the 
thymus 
Gadd45β-deficiency could be linked to an abbreviated phosphorylation of p38 in vivo and 
thus to a reduced cleavage of the effector caspase 3 (Höcker et al., in preparation). In order 
to ascertain that the reduced cleavage of caspase 3 is TCR-dependent, the apoptotic 
response of Gadd45β-deficient thymocytes to well-known apoptotic stimuli was analysed 
(Fig. 25). Interestingly, Gadd45β-deficiency led to an altered apoptotic response only upon 
αCD3 stimulation. Here, only low concentrations of αCD3 had opposing effects in wildtype 
and Gadd45β-/- thymocytes. Although αCD3 does not occur naturally, the huge differences in 
cell survival upon treatment with low concentrations can be interpreted as follows: Only 
physiological relevant concentrations of a given TCR stimulus lead to different outcomes in 
apoptosis. Specifically this correlation is well-described: the outcome of thymic selection 
processes is highly dependent on the strength of the TCR signal the T cells receives 
(Stritesky et al. 2012; Singer et al. 2008). 
This protection against apoptotic events upon a weak TCR stimulation would match the 
results obtained earlier in the laboratory using fetal thymic organ culture (FTOCs) (data not 
shown): Double positive thymocytes are protected against TCR-stimulation-dependent 
apoptosis. FTOCs have an advantage over αCD3 stimulation of complete mice: The 
potential side effects, namely a cytokine storm that is originating in the periphery, are 
eliminated (Martin and Bevan 1997). In order to show a relevance of these results in vivo, a 
Gadd45β-deficient mouse was bred to a N15H-2b TCR transgenic mouse on a RAG2-/- 
genetic background. Utilising this mouse, a cytokine storm could be excluded as an 
interference and thus, the obtained results were only due to downstream signalling events of 
the TCR that resulted from Gadd45β-deficiency. The analysis of these mice showed a 
pronounced increase in mature CD8+ T cells 48 h post TCR stimulation in terms of frequency 
as well as in absolute numbers (Fig. 28a+b). These cells have severely decrease of CD24 
expression, showing that they are mature T cells ready to leave the thymus and are not in an 
intermediated state of T cell development (Fig. 27). That this increased population of CD8+ 
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thymocytes is due to a defect in negative and not positive selection can be seen in the 
CD4+CD8+ double positive population: CD69 is comparable between wildtype and 
Gadd45β-deficient mice and expression of CD5 is more pronounced in wildtype T cells 
(Fig. 29). If anything, than this would imply more T cells in the wildtype and not in the 
Gadd45β-deficient situation. 
Of note, p38, JNK and the MEK5-ERK5 pathway have already been implicated in negative 
selection (Starr et al. 2003; Sohn et al. 2008). Thus, the interaction of Gadd45β and MEKK4 
with p38 is linked to negative selection by the MAPK. Importantly, Bim and Nur77 were 
shown to be crucial for negative selection (Bouillet et al. 2002; Calnan et al. 1995; Zhou et al. 
1996; Kuang et al. 1999). For Bim the means of acting on negative selection are self-evident: 
Being a pro-apoptotic Bcl-2 family member and its activity is regulated by MAPK-mediated 
posttranslational modification (Hübner et al. 2008). However, studies also showed a Bim-
independent way of negative selection (Hu et al. 2009; Kovalovsky et al. 2010). 
Nevertheless, Kovalovsky and colleagues could not totally rule out Bim-dependency in 
negative selection and Hu and colleagues found a Bim-dependency in double-positive 
thymocytes. If Bim is required for negative selection or not therefore remains a subject to 
debate and needs to be further investigated. 
Furthermore, the mechanism how Nur77 affects negative selection is still unclear. As a 
transcription factor, it may induce apoptosis in a transcription-dependent manner or by a 
direct interaction on Bcl-2 (Rajpal et al. 2003; Thompson and Winoto 2008). On the contrary, 
one study revealed that Nur77 is negligible for thymic and peripheral T cell death (Lee et al. 
1995). Taken together, only one study showed that Nur77 does not affect apoptosis in 
thymocytes, whereas multiple studies could prove otherwise. Thus, it is a well-accepted 
assumption that Nur77 plays a role in apoptosis in the context of negative selection in the 
thymus. Previous work could show that transcriptional levels of Bim and Nur77 remain 
unaffected in Gadd45β-deficient thymocytes (Keil 2008). Therefore, Gadd45β-MEKK4-p38 
interaction possibly constitutes a new signalling pathway in the negative selection process 
(Fig. 32). 
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Figure 32: Revised model of negative selection upon TCR stimulation in thymocytes. 
Upon a specific TCR stimulation, apoptosis is triggered in negatively selected thymocytes. Depicted 
are the published pathways, by which this selection process is mediated. Additionally, the new, 
suggested Gadd45β/MEKK4 pathway is depicted in parallel. 
 
Thus, it can be concluded that Gadd45β-deficient thymocytes, which should have been 
deleted in the context of negative selection in the thymus, instead mature and migrate into 
the periphery. Therefore, this defect in central tolerance possibly leads to the accumulation of 
autoreactive T cells in the periphery and subsequently to autoimmunity. This finding would 
also be in line with the reported increased autoimmunity of Gadd45β-deficient mice in 
contrast to wildtype animals (Liu et al. 2005).  
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6. List of abbreviations 
°C Degree Celsius 
7AAD 7-aminoactinomycin 
A Absorbance 
AIRE Autoimmune regulator 
Amp Ampicillin 
Atg Autophagy related gene 
Bak Bcl-2 antagonist killer 
Bax Bcl-2 associated protein X 
BCL-10 B cell lymphoma protein 10 
BCL-2 B cell lymphoma protein 2 
Bcl-xL Bcl-2-like 1 large 
Beclin 1 Coiled-coil, myosin like Bcl-2 interacting protein 
Bid BH3-interacting death agonist 
Bim Bcl-2-interacting mediator of cell death 
bp Base pair 
BSA Bovine serum albumin 
c-Flip Cellular FLICE-inhibitory protein 
CARD Caspase-recruitment domain 
CD Cluster of differentiation 
cDNA Complementary deoxyribonucleic acid 
DC Dendritic cell 
DD Death domain 
DED Death effector domain 
dH2O Distilled water 
DISC Death inducing complex 
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DMSO Dimethyl sulphoxide 
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
dNTP Deoxyribonucleoside-5´-triphosphate 
DP Double positive (CD4+CD8+) 
dsRNA Double stranded ribonucleic acid 
EAE Experimental induced encepahlomyelitis 
ECL Enhanced chemiluminescence 
EDTA Ethylenediamine tetra-acetic acid 
ELISA Enzyme-linked immunoabsorbant assay 
ER Endoplasmatic reticulum 
ERK Extracellular signal related kinase 
FACS Fluorescence activated cell sorter 
FADD FAS-associated death domain protein 
FITC Fluorescein-5-isothiocyanat 
Flip Flice-inhibitory protein 
Foxp3 Forkhead box protein 3 
g Grams 
Gadd Growth Arrest and DNA-Damage inducible gene 
GAPDH Glycerinaldehyd-3-phosphat-Dehydrogenase 
GST Glutathione-S-transferase 
h Hours 
Ig Immunoglobulin 
JNK Jun-kinase 
Kan Kanamycin 
kb Kilobase pairs 
kDa Kilodaltons 
l Litre 
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LB Luria-Bertani médium 
LC3 Microtubule-associated protein 1 light chain 3 
LPS Lipopolysaccharide 
M Molar 
mA Milliamps 
MAPK Mitogen-activated protein kinase 
MAPK Mitogen-activated protein kinase 
MEKK Mapk kinase kinase 
mg Milligrams 
MHC Major histocompatibility complex 
min Minutes 
MKK Mapk kinase 
ml Millilitres 
mM Millimolar 
mm Millimeter 
mol Moles 
mRNA Messenger RNA 
mTEC Medularry thymic epithelial cell 
mTOR Mammalian target of rapamycin 
NCBI National Centre for Biotechnology Information 
NF-κB Nuclear factor kappa-B 
ORF Open reading frame 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PCC Pigeon cytochrome C 
PCR Polymerase chain reaction 
RAG1 Recombination activating gene 1 
RAG2 Recombination activating gene 2 
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RNA Ribonucleic acid 
RNase Ribonuclease 
rpm Revolutions per minute 
s Seconds 
SDS Sodium dodecyl sulphate 
t Time 
TAE Tris-acetate EDTA 
Taq Thermostable DNA polymerase derived from Thermus aquaticus 
tBid truncated Bid 
TBS Tris-buffered saline 
TCR T cell receptor 
TEMED N,N,N´N´-tetramethyl-ethylenediamine 
Tet Tetracycline 
TGF-β Transforming growth factor-β 
TNF-α Tumor necrosis factor α 
TRAIL TNF-related apoptosis-inducing ligand receptor 
Treg Regulatory T cell 
Tris Tris(hydroxymethyl) aminomethane 
tRNA Transfer RNA 
V Volt 
v/v Volume for volume 
vol Volume 
VSV8 Vesicular stomatitis virus (octapeptide) 
W Watt 
w/v Weight for volume 
wt Wildtype 
µg Micrograms 
µl Microlitres 
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µM Micromolar 
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